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INTRODUCTION 
  
Neonatal sepsis is a clinical syndrome  which is accompanied  by signs 
and symptoms of infection during the first  4 weeks of life.1  “Suspected 
sepsis”   remains the most common diagnosis in NICU owing to its vague  
signs and symptoms. Though improved obstetrical management , intra-partum 
screening and evidence based use of antibiotics   are  practiced  now-a-days,  
sepsis  still remains   an  important  contributor to  mortality and  morbidity in 
neonates2.  
Neonatal mortality accounts for about 40% of deaths  under  five years 
of age. The global incidence  of neonatal deaths caused by sepsis is only 15% 
but in  a developing country like ours, sepsis accounts for about  30 to 50% of 
neonatal  mortality2. There has been a greater progress in decreasing  the   
post-neonatal causes of  mortality worldwide in the past few year resulting in 
a decrease in the  proportionate contribution  of neonatal mortality  to under 
five mortality. 
Despite the advances in neonatal care in the  recent years,  sepsis still 
remains a life- threatening condition. UNICEF data estimated  that  2.8 
million neonatal deaths that occurred  globally in  the  year 2013 were due  to 
sepsis. And two-thirds  of these  neonatal  deaths  have occurred  in the 
developing countries. 
The alteration in the immune system of  the neonates  in comparison to 
adults like reduced function of the neutrophils,  presence of low concentration 
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of immunoglobulins  and  defects in the complement system both qualitative 
and quantitative  makes them more susceptible to infections. 
The pathogenic organism  after  gaining access into the blood stream 
sometimes causes overwhelming  infection without any localisation resulting 
in septicaemia. Clinical suspicion and   timely diagnosis is important as even a  
few hours of  delay in initiation of treatment results in rapid clinical 
detoriation of  the neonate.  The causes of neonatal sepsis may vary from time 
to time  but it is usually of  bacterial origin. 
Based on the onset of symptoms and probable mode of transmission, 
neonatal sepsis  may be of  following  categories1: 
a.) Early onset  sepsis. 
b.) Late onset sepsis. 
c.) Very late onset sepsis. 
Early onset sepsis (EOS): 
The signs and symptoms of sepsis    present  within 72 hours of life3.                               
EOS is often associated with vertical transmission  by  the organisms 
ascending from the maternal genital tract or  transplacental transmission  
resulting in chorio-amnionitis or  fetal infection in- utero  or  by acquisition  
via passage through birth canal during labour. 
The  potential risk factors for acquisition of  EOS include1:             
i. prolonged rupture of membrane(PROM)     >12 hours 
ii. prolonged labour  >24 hours 
iii. febrile illness of mother prior to  2 weeks of  delivery 
3 
 
iv. prematurity < 36 weeks of gestation  
v. low birth weight < 2.5 kg 
vi. immune status,  
vii. resuscitation procedures etc.,    
The usual isolates of  EOS comprises of  Streptococcus agalactiae, E. 
coli, Klebsiella and  Listeria monocytogenes.  S.aureus & CONS are less 
frequent   causes3. 
Late onset sepsis (LOS): 
The signs and symptoms of sepsis  present  later than 72 hours of life3. 
The  origin of infection is usually from the environment.   The most common 
source of post-natal infection in hospital is due to the poor hand hygiene 
practices of  health care personnel. 
CONS   and other Staphylococci account for 30 to 60%  of  LOS owing 
to the use of intravascular devices especially in NICU setup.  The other 
organisms are S.aureus,  group B streptococci, Escherichia coli, Klebsiella, 
Enterobacter etc.  The risk factors include prolonged hospitalisation,  
indiscriminate  use of antibiotics, use of intravascular devices etc., 
Apart from bacterial causes,   candidemia especially  C.albicans and C. 
parapsilosis  also contributes to  LOS, especially in VLBW  infants1. 
Very late onset sepsis(VLOS):  
The usual onset of signs and symptoms is after the neonatal period  
(i.e)  > 1 month  of   life. 
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SIRS is the systemic response to the invasion and infection in neonates 
which  may present as  refusal to take feeds, hypo or hyperthermia etc.  Since 
the signs and symptoms of  sepsis and  systemic inflammatory response 
syndrome( SIRS)  in neonates  are  variable and subtle, it  makes neonatal 
sepsis   clinically  indistinguishable from certain non- infectious diseases like 
respiratory distress syndrome.  So  the laboratory investigations  play a vital 
role in arriving at a diagnosis of sepsis. 
Blood culture remains the gold standard and goes hand in hand with the 
clinical symptoms in arriving  at  the diagnosis4.  But it is time consuming, 
require well equipped laboratory and trained personnel.  And   not  all the 
cases of neonatal  sepsis show culture positivity. In case of neonatal sepsis the 
culture positivity  is only moderate. 
So development of  novel early  diagnostic  markers of  sepsis like   
pro-calcitonin, interleukin-6, C-reactive protein etc., help  in early  assessment  
of  infection, reducing the mortality and  sequelae. They are now used  in 
conjunction  with  blood culture  in   diagnosing  sepsis  in  neonates. 
All these  variables  help in very early diagnosis and   in  prompt 
institution of  anti-biotic therapy only  when  indicated thus avoiding  their 
indiscriminate usage5,6. This helps the neonate to bypass the unnecessary 
adverse effects of anti-biotic administration, makes the treatment cost-
effective and    prevents the  emergence of  multi- drug  resistant  strains. 
The number of studies based  on neonatal sepsis  done  so far  in 
Tamilnadu or South India   is  found to be  limited  which  makes it imperative 
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to study  the   bacterial isolates from neonatal sepsis in our own institution.  In 
order to  monitor  the common isolates and their anti-microbial susceptibility 
pattern  periodically and to gain knowledge about  the risk factors  
contributing to sepsis in neonates  this study seems inevitable. 
With this  objective,  the prospective study  “ Correlation between 
CRP,  procalcitonin and  blood culture in diagnosis of neonatal sepsis  with 
special reference to the bacteriological profile &  antibiotic  susceptibility 
pattern of the isolates at CMCH”  was undertaken to know the incidence of 
neonatal sepsis at our institution  and to determine the value of  other  
diagnostic markers of sepsis in comparison to blood culture.  
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AIMS AND OBJECTIVES 
AIM: 
To correlate CRP, procalcitonin and blood culture in diagnosing  sepsis 
in neonates. 
OBJECTIVES: 
1) To compare CRP and procalcitonin with culture positivity in 
diagnosing neonatal sepsis. 
2) To correlate culture proven sepsis with  maturity of the neonate, birth 
weight and mode of delivery. 
3) To determine the bacteriological profile of neonatal sepsis. 
4) To evaluate the anti-microbial susceptibility pattern of the organisms 
isolated.  
5) To estimate ESBL production among the Gram negative isolates.  
6) To predict the value of altered WBC  and platelet counts in diagnosing 
neonatal sepsis. 
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REVIEW OF LITERATURE 
 
Sepsis in neonates presents as a  clinical syndrome characterised by   
systemic signs of   infection with   bacteremia during the first 4 weeks of life.                                    
Based on the onset of symptoms and presentation sepsis in neonates  is 
grouped  into: 
                          1)  Early onset sepsis (EOS) 
                           2) Late onset sepsis (LOS) 
                           3) Very late onset sepsis (VLOS) 
EPIDEMIOLOGY: 
The global distribution of neonatal mortality due to sepsis is estimated 
to be 1.6 million per year. Nearly 40% of this mortality happen in the 
developing countries7,8,9.   Reported incidence of neonatal septicaemia is about 
42 per 1000 live births in Africa, 17 per 1000 live  births  in Latin America 
and the Caribbean regions10. The overall incidence of culture proven sepsis in 
developed countries  is 1-8 per 1000 live births. 
Incidence of neonatal  sepsis in India   varies from  4.8  to 20.7 per 
1000 live births while  that  of meningitis is found to be 3 per 1000 live 
births11. Fatality due to sepsis ranges between 40- 65 % accounting for about 
one fourth to nearly half of neonatal mortality in India. 
 Early onset sepsis is reported to be more severe having a higher case 
fatality rate than  late onset sepsis in developed countries.  As CONS  is the 
common causative organism of  LOS, the mortality associated with it is  low.  
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But this is not the case in developing countries, where Gram negative bacteria 
are commonly  involved in LOS making it more severe and accounting for 
higher mortality than EOS.  
EARLY ONSET SEPSIS: 
Early onset sepsis is acquired before or during delivery. The 
presentation is usually <72 hours of birth. It is usually associated with 
maternal obstetric complications, prematurity, multi system manifestations. 
Very low birth weight neonates ( <1000 gm) are more prone  for early onset 
sepsis.        
The risk factors for early onset sepsis include12,13: 
a) chorio-amnionitis  
b) Preterm birth (less than 32 weeks),   
c) Prolonged labour >18 hours,  
      d) Prolonged rupture of membranes,  
      e) multiple vaginal examinations especially with ruptured membrane, 
 f) meconium stained amniotic fluid,  
g) colonisation of microorganisms in the maternal genital tract  
 h) Low socio-economic status 
i) low APGAR score 
j) other complications of delivery  & labour. 
LATE ONSET SEPSIS: 
In   late onset sepsis, the  presentation is after 3 days of life with  the 
peak incidence  usually occurring  between 10th & 22nd day of life. The 
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incidence of LOS has increased with  improved survival of the premature 
neonate  especially those with  VLBW. This  indicates that hospitalisation and 
life sustaining devices are involved in the pathogenesis of LOS. In case of late 
onset sepsis  nosocomial infections  contribute to significant mortality. It 
includes infection which are  not  tranplacentally   acquired but occurring  post 
to  admission in the neonatal intensive care unit. 
The risk factors  for LOS include14: 
a) Prematurity 
b) Low birth weight 
c) Procedures done invasively 
d) Catheters in situ 
e)  lipid emulsions as parenteral nutrition 
f) Endo-tracheal tubes. 
VERY LATE ONSET SEPSIS:  
Here  the signs and symptoms are apparent after 1 month of birth. It 
occurs particularly in very low birth weight babies (VLBW) or in term babies 
who require prolonged  care in NICU.                      
One third of the VLBW infants with sepsis are  negative  for blood 
culture  inspite of higher incidence of meningitis. This  discordance between 
the   culture and high clinical suspicion of meningitis  in   these  babies 
emphasises the need for CSF culture in suspected neonatal sepsis. 
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BACTERIOLOGICAL SPECTRUM: 
The bacteriological spectrum causing  neonatal sepsis  shows marked 
geographic variation. They may  vary at different times in the  same place. 
Any micro-organism that colonise  the maternal  genito-urinary tract or gastro-
intestinal tract may result in intra-partum as well as post-partum infection. 
Shaw CK et al from Nepal in the year 2007 reported that 
Staphylococcus aureus was the most frequent  organism  ensued  by Klebsiella 
and E.coli  in causing sepsis in neonates15. 
Ziba mosaiebi et al (2003) from Iran reported that the most common  
organism  isolated from  neonatal sepsis was  Klebsiella followed by 
Staphylococcus aureus, E.coli, Pseudomonas, Acinetobacter16.   Klebsiella 
was the commonest organism  causing EOS while Staphylococcus aureus  was 
the commonest isolate in LOS. 
Rahman et al from Pakistan (2002) reported that the most common 
organism isolated from sepsis in neonates was Escherichia coli followed by 
Staphylococcus , Pseudomonas and Klebsiella.17 
Gram negative organisms are more frequently   responsible for sepsis 
in neonates (65-85%) when compared to the Gram positive organisms. 
Commonly found isolates are Klebsiella, E.coli, Pseudomonas, 
Staphylococcus aureus , Enterobacter, Citrobacter, Proteus and Group B 
Streptococcus. 
Shalini Tripathi et al (2010) from India reported  Klebsiella 
pneumoniae to be the commonest organism contributing  32.5% and   S.aureus 
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(13.6%)  as  the second common cause  of sepsis in intramural neonates14. In 
case of extra-mural admissions , sepsis accounts for 38 % of deaths where 
Klebsiella(27.5%)  was the commonest  followed by Staphyloccocus 
aureus(14.9%). Though the commonest isolates are the same, the mortality 
tends to be higher in extramural cases. 
Zakariya et al in the year 2010 from Pondicherry has stated  that  
Klebsiella pneumoniae  was  the  commonest  organism causing  sepsis in 
neonates especially in developing countries.3 
ETIOLOGY OF NEONATAL SEPSIS: 
In general, the common bacterial causes of early onset sepsis (EOS) 
include1: 
 
a) Group B- streptococcus 
b) Escherichia coli 
c) Streptococcus pneumoniae 
d) Viridans streptococci 
e) Enterococci 
f) Haemophilus influenzae 
g) Neisseria  meningitidis 
h) Neisseria gonorrhoea 
i) Listeria monocytogenes etc., 
   Of these, Group B- streptococcus and Listeria monocytogenes are 
usually of maternal origin. 
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The common bacteria causing late onset sepsis include1: 
a) Staphylococcus aureus 
b) Coagulase negative Staphylococci 
c) Enterococci 
d) Citrobacter 
e) Enterobacter 
f) Klebsiella pneumoniae 
g) Salmonella 
  Coagulase negative Staphylococci and Staphylococcus aureus  in case 
of Gram positive bacteria, E.coli & Klebsiella are found in frequent  
association with first episode of  LOS in  infants of  very low birth weight. 
Agents that are implicated to cause nosocomial infection include 
CONS,   Escherichia coli,  Klebsiella pneumoniae, Salmonella, Enterobacter 
aerogenes,  Pseudomonas,  Serratia and Citrobacter. 
The non-bacterial causes of neonatal sepsis include : Adeno virus, 
Cytomegalovirus , Enterovirus, Human Herpes viruses including  HSV and 
VZV, HIV, Parvovirus, Rubella virus, Candida species, Plasmodia, 
Toxoplasma gondii etc., 
Infection acquired by the neonates after discharge are usually 
community acquired. 
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NEONATAL IMMUNITY: 
The immune system and its response in neonates is different from that 
of adults.  Both qualitative and quantitative defects have been observed and 
demonstrated in term as well as preterm neonates. 
Neutrophils or the polymorphonuclear cells play a vital role in effective 
killing of bacteria. In neonates there is reduced adhesion and adherence of 
these cells  to the  lining vascular  endothelium   which further decreases its 
migration into the tissues.  
Also these polymorphs show deficient chemotaxis (neutrophil 
migration) because of the  reduced expression of  β-2 integrins , selectins and   
cell membrane  adhesion molecules. Neonatal polymorphic cells are less 
deformable than adults. This limits the phagocytic activity of the cells  and 
efficient  killing of  bacteria is  impaired further  in sepsis. Easy depletion of 
neutrophil reserve due to reduced bone marrow response   makes the neonate 
more susceptible to infection. 
The neonatal macrophage and monocyte chemotaxis is impaired in 
early childhood as compared to adults. It includes the circulating monocytes 
as well as the macrophages in liver, spleen and lungs  which are responsible 
for immune modulation. The chemotactic, bactericidal, cytokine producing 
and antigen presenting activity of the monocyte-macrophage system are less 
competent at birth.        
Activation of T-cells in neonates results in ineffective production of 
cytokines which participates in the stimulation of  B-cells  and their further 
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differentiation. The neonates are deficient of memory T-cells as well. 
Subsequent exposure of the neonate to the antigenic stimuli increases the 
memory T-cells. 
In neonates  NK cells are seen in far fewer numbers in peripheral 
circulation which are  functionally immature  resulting in lower levels of  
interferon-γ  synthesis on primary stimulation than the normal natural killer 
cells. 
As far as the humoral immunity is concerned , the ability of the neonate 
to generate immunoglobulin for an antigenic stimulus is initially low at birth. 
But the magnitude of this response rises rapidly with increase in post-natal 
age. Newborns usually lack antibody mediated protection against 
Enterobacteriaceae  especially E.coli.   
The neonate is able to  synthesis  IgM, IgG, IgE in utero1. Large 
proportion of  IgG in neonates is maternally  acquired in the  late gestational 
period.  Its specificity is determined by the mother’s previous antigenic 
exposure and lower levels are found with  increasing prematurity. This 
maternally derived antibody falls rapidly after birth. The neonate is not 
capable of secreting IgA till 2-5 weeks after birth and receives it from the 
mother during breast- feeding. In total, the response to the polysaccharide 
antigens is diminished. 
 The  concentration of the components of complement system   vary 
widely among the neonates though their synthesis starts in the early gestation. 
The deficiency of the complement system is more observed in the alternate 
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pathway than in the classical pathway.  Premature  neonates have still lower 
levels  of complement activity.  
 The terminal cytotoxic components in the complement system that are 
responsible for efficient killing of Gram negative bacteria are deficient in 
neonates. Complement system is mainly responsible for bactericidal activity 
against E.coli and act as opsonins along with the antibody in phagocytosis. 
Because of lower levels of fibronectin which is involved  in neutrophil 
adherence and opsonisation , neonates show reduced opsonic efficiency 
against E.coli, S.pneumoniae, Group B Streptococci etc. 
The neonatal immune system with the individual deficiencies of the  
components   and  interdependence of all these factors in order  to evoke an  
immune response as a whole conspire  to convert  the  situation to a great  
hazard on exposing  the  neonate   to infectious threats.  
PATHO-PHYSIOLOGY:  
The unique pathophysiology  contributes to the clinical syndrome of  
neonatal sepsis. Neonates are less efficient in triggering response to  infection 
due to  their deficient immune status  compared to adults. Conditions  co-
existing with sepsis renders  the diagnosis a complex process as its  
manifestations  vary in neonates. 
The pathogenesis depends on the following factors: 
o the time of exposure, 
o  status of the  host immune system and its response,  
o quantity of the  inoculum,  
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o virulence of the infecting microorganisms,  
o maturity of the neonate,  
o underlying comorbid conditions,  
o  procedures done invasively,  
o genetic predisposition 
o presence of transplacental maternal antibodies. 
Transplacental infections can occur at any stage of gestation and its 
presentation varies. The timing of the infection during gestation determines 
the outcome. The  fetus is maintained optimally in a sterile environment 
before birth. The organisms causing sepsis ascend from the maternal genital 
tract either during the rupture of amniotic membrane or during the course of 
labour which results in infection. 
Chorioamnionitis which is the intra- amniotic infection is a major risk 
factor for EOS. Here sepsis begins in utero when the foetus inhales or 
swallows the infected amniotic fluid. The neonate can present with the 
symptoms within hours or days of birth when the colonised skin or mucosa is 
compromised.   
Pyati et al(1983)  reported that the preterm neonates are exposed to 
Group- B Streptococci in utero while the term neonates are often exposed to 
the organisms while passing through the birth canal18.  
After birth, the neonates may acquire infection from  mother and 
family members, inanimate sources used for resuscitation or health personnel 
17 
 
via direct contact . Most meningitis cases are due to hematogenous 
dissemination and less often due to contiguous spread. 
Mechanisms for elimination of the organisms are activated  when  
bacteria  gain access into the blood stream of the neonate. Normally the 
bacteria are efficiently killed by the monocyte-macrophage system. However, 
sometimes it may develop systemic inflammatory response syndrome and 
progress into sepsis.  
The earlier belief that  the bacteria and their components like 
endotoxins (lipo-polysaccharides) of Gram negative bacteria and lipo-teichoic 
acid of Gram positive bacteria were responsible for the direct toxic effects is  
now being  replaced. Recent studies show that  the pathological effects of 
sepsis  generated by the bacterial infection are mainly mediated  by the 
interaction of the inflammatory cytokines activated in response to these 
microbial components in the vascular compartment. 
MARKERS OF NEONATAL SEPSIS: 
Many circulating and cell associated molecules such as total leucocyte 
count, absolute neutrophil count,  ratio of total & immature neutrophils, C-
reactive protein , various cytokines including IL-6 &8 and  TNF-α ,  
procalcitonin are proposed as useful markers in diagnosing sepsis19,20. But 
none of them are found to be 100% sensitive or specific. Though  the gold 
standard method  for diagnosing sepsis is blood culture , rapid diagnostic 
methods to  detect these  biological markers could be an added advantage. 
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As a  sequelae  to inflammation,  haematological response  including   
alteration in complete blood counts, platelet number and absolute  neutrophil 
count occurs in a neonate.                              
Estimation  of  WBC, absolute neutrophil count and micro ESR  can be 
done. The   value of total leucocyte  count in predicting sepsis  is considered          
non-specific  as it is normal in  one-third of  neonates  showing culture 
positivity. So it cannot be taken as a sole  reliable marker in diagnosing  
sepsis.  Leucopenia  is  considered a  fairly  specific indicator  in detecting 
sepsis than leukocytosis. 
Among the  neutrophil indices,   absolute neutrophil count (ANC)  has 
the highest specificity and sensitivity than total leucocyte count especially in 
below normal range which makes it a better marker when compared with 
other markers. 
As a prognostic indicator platelet count has gained much less 
significance  because of its limited predictive value. As a late event in 
bacterial infection nearly 50% of them develop thrombocytopenia  making it a 
less reliable marker. It is also elevated in a number of disorders other than 
sepsis. 
INTERLEUKINS: 
Interleukins are products of leucocytes that exert regulatory influence 
on the other cells. They are grouped under cytokines which are peptide 
mediators that regulate inflammatory, immunological and reparative host cell 
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responses. They are hormone like substances that are highly potent and active 
even at femtomolar concentrations. 
Interleukins are produced by widely distributed cells such as 
lymphocytes, macrophages, fibroblasts and platelets. They do not act 
systemically but act locally near the producing cell (paracrine effect) or 
directly on the producing cell (autocrine effect). In general they are 
pleotrophic and there is considerable overlap in the effects produced by 
different cytokines.  
The important cytokines that act as biological markers of sepsis are 
interleukin-6, interleukin-8, tumor necrosis factor–α. 
Interleukin-6 is produced by activated T-cells, B-cells, macrophages 
and fibroblasts in response to infection and trauma. It can act as  a  pro-
inflammatory cytokine as well as anti- inflammatory myokine. 
Immunoglobulin synthesis by activated B-cells and formation of receptors for 
interleukin-2 on the surface of T-cells are mediated by IL-6.  
IL-6 promotes the production of C-reactive protein as it is a potent 
inducer of  hepatic protein synthesis and also activates T-cells and help in 
their differentiation into cytotoxic T-cells and also plays  a role in the release 
of other cytokines like     TNF-α, IL-1β.21 
Yoon BH et al (2000) and Naccasha et al (2001) reported that  
umbilical cord blood had substantially elevated levels of IL-6  in newborns  
with early onset sepsis and mothers with  chorio-amnionitis.22,100  Researchers 
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found that repeated evaluation of IL-6 after 12-24 hours is not necessary as 
they tend to go back to the initial levels.   
Interleukin-8 is produced mainly by activated macrophages. The 
protein coupled serpentine receptors CXCR-1 AND CXCR-2 are the receptors 
for IL-8. Expression and affinity differs between the two receptors.  It mainly 
acts as neutrophil chemotactic factor which primarily mediates two functions  
chemotaxis and angiogenesis. It is a pro-inflammatory cytokine. 
According to Franz AR et al (1999)  both IL-6 and IL-8 are found in 
elevated  levels   neonatal  as  well  as  adult  sepsis23.   IL-8  serves  as  a 
marker  of  sepsis  according  to  studies  by  Berner  et  al  (1998)   and    
Irmeli Nupponen et al (2001).24,25 
Tumour necrosis factor-α is a potent pro-inflammatory cytokine with 
pleotropic effects in host defence against pathogens produced mainly by  
monocytes, macrophages and lymphocytes. All cells and tissues serve as a 
potential target for its action. TNF mediated effects show two facets. On one 
hand , evidence is growing that it is involved in a number of pathological 
processes. On the other hand it is believed to be crucial for the  successful 
development of anti-microbial immune response.                
 
C-REACTIVE PROTEIN: 
Most forms of tissue injury  triggers  the cytokine mediated response 
resulting in  dramatic elevation of the circulating levels of CRP, a normal 
plasma protein.  So it is considered a prototype acute phase reactant playing 
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an important role in innate immunity.   This plasma protein is synthesized in 
the hepatocytes during infection and inflammation. 
Darren Thompson et al (1999) reported that the  cation (Ca2+) mediated  
specific binding  of  the  phosphocholine  ligand  in addition to  failure to 
detect any polymorphism due to its conserved structure depicts essential role 
of CRP Iin diagnosing sepsis.26 
It belongs to the   pentraxin family which is a small, well conserved 
and evolutionarily ancient group. It has 224 amino acids with a molecular 
weight of 25 kDa  and has annular pentameric disc shape. It was discovered in 
1930 by Tillet and Francis from the serum of the patients with acute 
inflammation. It was named so  due to its reaction  with the ‘C’-
polysaccharide of Streptococcus pneumoniae.97 It has been frequently used in 
investigating and monitoring neonatal sepsis. 
Marnell et al (2005) reported that C-reactive protein is an indicator for 
acute inflammation and infection.27 
According to Sierra et al (2004) CRP raises up to thousand folds in 
case of systemic infections caused by all  bacteria.28 
Chauhan Setal B et al (2012) reported that  CRP shows a rapid rise 
within 12 to 24 hours of sepsis and  have further incremental increase 
thereafter.29 
According to Rodwell RL et al (1993) C-reactive protein has practical 
added advantage over the  other biological markers of sepsis as  serum levels 
of CRP is not influenced by prior  antibiotic administration30. But still it is 
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recommended to consider  the  laboratory findings and clinical aspects 
together  to establish a confirmed   diagnosis of sepsis. 
As a part of innate immune response , CRP contributes to the host 
defense within hours of tissue injury and infection which can be demonstrated  
by its rapid elevation in the serum. Elimination of the microbial stimulus from 
the body results in quick fall of the serum CRP levels due to its shorter half 
life of approximately 19 hours.  
Volanakis and Kaplan identified that the phosphocholine in the ‘C’ 
polysaccharide cell wall is the ligand for C-reactive protein.107 
C-reactive protein can : 
 bind to immunoglobulin receptors. 
 stimulate phagocytosis 
 activate the classical complement pathway. 
Their tendency to recognise pathogens followed by  subsequent  
activation and recruitment  of the complement system along with their opsonin 
mediated phagocytic effect  constitute the  first line host defense mechanism 
against infections. 
Apart from Streptococcus pneumoniae, CRP can directly bind to 
Haemophilus influenza according to Weiser JN et al (1998) and  Lysenko et 
al(2000) and Salmonella enteric  serovar typhimurium as evidenced in studies 
by  Szalai et al -2000.31,32,33 
           Hussein A Baineh, Khaled M Al-Rashed (2007) reported that the acute 
phase reactant CRP may rise more than 1000 times in sepsis.34          
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According to them CRP may be used as a parameter to identify the 
appropriate time  to safely discontinue the antibiotic course. 
The ability of CRP to initiate  tissue factor  production with 
complement activation  resulting in its pro-inflammatory and pro-coagulant 
effect suggest that CRP is  not only involved in infection and inflammation 
but also contributes to the pathogenesis  and progression of thrombo-occlusive 
diseases and it can be considered as a potential therapeutic target in  those 
cases.  
 
PROCALCITONIN: 
Procalcitonin , the peptide precursor of  hormone calcitonin  is made of 
116 amino acids with molecular weight of 13 kDa. It is encoded in the CALC-
1 gene on chromosome 11. CT-DNA is translated into mRNA  and the first 
translation product is pre-procalcitonin.  
           Procalcitonin is produced  by parafollicular ‘C’ cells of  thyroid gland 
along with  neuro endothelial cells of lungs  as the expression of CT-mRNA 
occurs only in these tissues. This usual method of synthesis is called ‘ neuro-
endocrine pathway’ which  occurs in normal individuals. The synthesised 
procalcitonin  is cleaved intracellularly  by the proteolytic enzymes into low 
molecular weight peptides, finally forming   Calcitonin- a 32 amino acid 
compound.  
         It is also synthesised by monocytes and macrophages  in case of severe 
bacterial infection and sepsis by means of ‘alternate pathway’ which was first 
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described by Muller et al(2001).35 According to them, the inducers for the 
production of procalcitonin by means of this alternate pathway are the 
inflammatory cytokines like interleukins, TNF-α, lipo-polysaccharide of 
bacterial cell wall etc.                            
The circulating level of procalcitonin is below the limit of detection in 
normal  individuals. But   in case of  severe infections  with Systemic 
inflammatory response syndrome(SIRS) or sepsis, the blood levels of 
procalcitonin may go to >100 ng/ml. Procalcitonin levels do  not rise 
significantly in case of viral and other non-infectious inflammations. 
Procalcitonin is useful in various clinical situations like  differentiating 
bacterial from viral infections, determining the duration of anti-biotic therapy, 
diagnosis , risk stratification and monitoring  sepsis, evaluating the response to 
antibiotic therapy, diagnosis of septic arthritis, diagnosis of bacterial infection 
in neutropenic patients etc., 
According to Weglohner et al (2001), in case of sepsis only the  3-116 
fragment is detectable in the serum and not the complete procalcitonin 
molecule.36 
Linscheid et al (2004) reported the mechanism  involved in synthesis of 
procalcitonin  during sepsis. Cytokine stimulated adherent monocytes produce 
an initial pro-calcitonin burst which continues as long as the stimulus for 
synthesis exists.37 
           It was clarified in research  that cells exposed and treated  only with IL-
1β( released only in  bacterial sepsis) induced the release of procalcitonin 
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while the cell when treated and exposed to  both IL-1β and  INF-α ( released 
by virus infected cells) simultaneously  do not synthesis procalcitonin making 
it a perfect tool to differentiate bacterial and viral infections. 
Meisner (2000) reported that the half life of procalcitonin in the serum 
is 25 – 30 hours. So as sepsis resolves PCT values reliably return backs to its 
normal value.38 
           Stuber et al (2001) reported that PCT levels can be  used as a reliable 
marker in  life threatening  sepsis  to monitor the course,  predicting prognosis 
and also helps in efficient  tailoring of  therapeutic  interventions.39  This was 
demonstrated by Luyt et al (2008)  in monitoring the treatment and outcome in  
ventilator associated pneumonia (VAP).40 
           The conversion of  pro-calcitonin to calcitonin is inhibited by the action 
of various cytokines and endotoxins released during infection. Hence when  
the endotoxins of Gram negative bacteria increases, the level of procalcitonin 
eventually rises serving as a marker of sepsis and its increase is not associated 
with parallel increase in calcitonin levels.  
           The beneficial role of procalcitonin in diagnosing  sepsis in neonates  
has been thoroughly investigated and positively reported by Zahedpasha et 
al(2009), Carol ED et al (2002).41,42 Rise of serum procalcitonin levels to        
> 0.5ng/ml is considered significant in sepsis.  
           Harbarth et al (2001) and Muller et al(2001) reported that serum 
procalcitonin  when compared to other markers show early and specific rise in 
sepsis  which can be observed within 3-6 hours of initiation of sepsis.35,41 
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But there are  certain situations in which procalcitonin is elevated due 
to a non-bacterial cause include massive stress states  and treatment with 
agents that stimulate cytokine release  like anti-lymphocyte globulins, 
alemtuzumab, granulocyte transfusion, malaria,  vasculitis, acute graft vs host 
reaction and para-neoplastic syndromes. 
CLINICAL MANIFESTATIONS: 
           The unique  process of  infection and  its subsequent systemic response  
is known as Systemic inflammatory response syndrome (SIRS). In neonates 
SIRS manifest as  hypothermia/hyperthermia, altered gas exchange,  
respiratory distress , hypoxemia, perfusion abnormalities resulting in oliguria 
and metabolic acidosis. This escalating tissue injury due to the cascade of 
events occurring in SIRS  when untreated progress to sepsis resulting in 
multisystem organ failure and death..                            
The clinical presentation may be : 
a) Non- specific signs and symptoms. 
b) Specific features pertaining  to the organ  systems. 
The earliest signs and symptoms being subtle, a high degree of 
suspicion is essential for early diagnosis. The presentation may be with one or 
more of the following features-  fever or hypothermia (the latter being more 
common), poor cry , refusal to feeds, lethargy, prolonged capillary refill time , 
poor perfusion, absent neonatal reflexes, hypotonia, tachy/bradycardia, 
apnoea, gasping and respiratory distress, hypo/hyperglycaemia, metabolic 
acidosis. 
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The specific features related to various systems include14: 
a) Central nervous system:  The following  symptoms  should raise high  
suspicion of meningitis -  high pitched cry, bulging anterior fontanelle, 
vacant stare,   stupor, irritability , seizures and  coma. 
b) Cardio-vascular system:   reduced  perfusion, hypotension and shock. 
c) Gastro-intestinal :  Abdominal distension, feed intolerance,  vomiting, 
diarrhoea, paralytic ileus. 
d) Hepatic:  Direct hyperbilirubinemia, hepatomegaly. 
e) Acute renal shut down 
f) Haematological: Bleeding, petechiae, purpura 
g) Skin changes:  areas of  mottling,  discharge from umbilicus, pustules 
and abscesses. 
 
DIAGNOSIS:                             
Maternal history which gives useful information regarding ante-natal 
exposure to infection, immune status , colonisation and presence of any other 
obstetric  risk  factors  along with the clinical features  play an important  role 
in diagnosing sepsis. 
           Laboratory  diagnosis  which supports the evidence of infection like 
isolation of microorganism  from a normally sterile site like blood, cerebro-
spinal fluid or demonstration of the organism in tissues/fluid , molecular 
diagnostic tests and serological tests to detect the biological markers of sepsis  
can be performed  to establish  the diagnosis. 
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Since blood culture is considered the gold standard for diagnosing 
sepsis it is mandatory to perform it  in all cases of clinical suspicion  before 
initiating  antibiotic therapy.  A positive blood culture with anti-microbial 
sensitivity of the isolated  microorganism  is the best guide to  anti-microbial 
intervention. 
ANTI-MICROBIAL RESISTANCE: 
Drug resistance is a threat for the survival of the newborns with sepsis 
as there are only limited therapeutic choices available  for this group.  There is 
an  increasing trend  of resistance to the most commonly used antibiotics all 
around the world. The emergence of resistance is the characteristic feature of 
bacterial  evolution and  it seems to be unavoidable. 
Most clinically relevant bacteria are capable of expressing and 
acquiring drug resistance. Once the organism is isolated in the laboratory , 
characterisation of the organism which includes  tests to determine resistance 
pattern must be done. 
           Successful  bacterial resistance to an antibiotic requires interference in 
one or more of the following steps essential for effective action of the 
antimicrobial agent45 :  
1) anatomic approximation  
2) surface binding (adsorption) 
3) intracellular uptake 
4) target binding 
5) growth inhibition/lysis and death  
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The common pathways  of drug resistance in general includes 
enzymatic destruction of the antibiotic, altered target of action resulting in 
decreased affinity or reduced binding of the antibiotic to the target, decreased 
intracellular uptake or increased efflux of the drug.  Among these the bacterial 
destruction  of  the  β-lactam ring is the commonest  method of resistance 
among the β- lactam antibiotics. 
Since the  discovery of  penicillin, the first β-lactam antibiotic was the 
antibiotic of choice for many years to come. But bacteria developed 
mechanisms to escape from the action of this antibiotic by the production of β-
lactamase enzyme. TEM-1 was the first plasmid mediated β-lactamase 
described in 1960’s. The organisms which are isolated from intensive care 
units tend to have high degree of antibiotic resistance. 
Over the past two decades many newer β-lactam antibiotics have been 
developed which are specifically designed to combat the hydrolytic action of 
the β-lactamases. Because of inappropriate and extensive use of these new 
compounds in addition to the mutation of these β-lactamases, the emergence 
of drug resistance raised tremendously in recent years. 
There are four major groups of antibiotics in the β-lactam  group which 
are  Penicillins, Cephalosporins, Monobactams and Carbapenems.  
After their discovery in 1980’s, the  third generation cephalosporins 
were widely used in treatment of Gram negative bacteria. They are called as 
Extended Spectrum β-lactams because of their expanded spectrum of action. 
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But bacteria soon developed extended spectrum  β-lactamases (ESBL) 
that mediate resistance in these group  of drugs which includes ceftazidime, 
cefotaxime, ceftriaxone and monobactams  like aztreonam without affecting 
the activity of cefamycins like cefoxitin and cefotetan or carbepenamases like 
meropenam and imipenem. 
β-lactamases are a diverse group of enzymes having over 340 different 
enzymes. Amp-C β-lactamase was the 1st identified enzyme of this group. 
They  are traditionally classified  based on either their primary structure or 
functional characteristics of the enzyme. Based on the protein sequencing  of  
the conserved  and  distinguishing amino acid motifs,  there are  four 
molecular classes-A,B,Cand D which constitutes the ‘Ambler’s classification’. 
Classes A ,C and D (considered serine based) include enzymes that 
hydrolyse their substrate by forming acyl enzyme through an active site 
serine. Class B are metallo-enzymes which utilise at least one active zinc ion 
site to facilitate β-lactam hydrolysis. 
According to Karen Bush and George A. Jacoby (2010) though  the 
most convenient  and  the  least controversial method to classify this diverse 
group  of enzymes  is by the structural approach , a classification based on 
functional characterization would give an opportunity to associate  these  β-
lactamases with their  clinical  role by exerting a selective resistance to  
different class of β-lactam antibiotics.46 
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In the functional classification the β- lactamases   are aligned based on 
the ability to hydrolyse the specific β-lactam class along with the inactivation 
property of the β-lactam inhibitors clavulanic acid, tazobactam and sulbactam. 
Modified Bush – Jacoby Medeiros classification of β- lactamases has 4 
groups. 
Group 1- β-lactamase:      
 Cephalosporinases belonging to molecular class C 
 Encoded on the chromosome of many Enterobacteriaceae members. 
 Resistant to  inhibition  by clavulanic acid. 
 Have higher affinity for aztreonam in contrast to Class –A. 
 Lack of action on cefoxitin and inhibition by tazobactam and 
clavulanate 
 Production of resistance to cefotaxime and not ceftazidime. 
According to Bradford et al (2004), Jacoby et al (2004) and Quale  et al 
(2006) when this group 1 cephalosporinase are produced in large amounts in a 
host with reduced β-lactam accumulation, they can even  provide resistance to 
carbapenems mainly ertapenam. 
Group 2 – β-lactamase:  
 include molecular class A and D   
 largest group of β-lactamases primarily due to the  increasing rates of   
ESBL production. 
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Subgroup 2a penicillinases:   
 limited spectrum of hydrolytic activity   
 hydrolyze benzyl penicillin and have poor action on cephalosporins.   
 Mostly  chromosomal mediated and  inhibited by clavulanic acid 
 Subgroup 2b β-lactamases:  
 Hydrolyze penicillins and early cephalosporins like cephalothin   
 Inhibited by strongly by clavulanic acid and tazobactam.   
 TEM-1, TEM-2 and SHV-1 are the most common plasmid mediated β-  
lactamases. 
 Subgroup 2be: 
 Comprises of extended spectrum β-lactamases.  
 Large spectrum enzymes  active against one or more of the oxy-imino  
β-lactams like cefotaxime, ceftriaxone, ceftazidime and aztreonam.    
 Unlike TEM and  SHV ESBLs, CTX-M are inhibited by tazobactam 
more than clavulanic acid.  
 The less common ESBLs are BEL-1, BES-1,SFO-1,TLA-1, TLA-2, 
PER, VEB   
 Subgroup 2br:  
 Broad spectrum β-lactamases  
 Have acquired resistance to clavulanic acid  
 Retain subgroup 2b  spectrum of activity.  
 36 of 135 functionally characterised TEM enzymes and  5 of 72                                     
functionally characterised SHV ezymes belong to this group.   
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Subgroup 2ber : 
 TEM enzymes that combine an extended spectrum  
 show relative resistance to clavulanic acid inhibition.  
 also  termed  as CMT (complex mutant TEM) lactamases.  
 Subgroup 2c penicillinases: 
 Hydrolyze carbenicillin or ticarcillin.   
 Easily inhibited by clavulanic acid or tazobactam. 
 Subgroup 2d  : 
           Distinguished by their ability to hydrolyze oxacillin or cloxacillin at a 
rate of more than  50% than benzylpenicillin  
Subgroup 2de: 
 Oxacillin or cloxacillin hydrolyzing enzymes with an extended 
spectrum   which includes oxyimino--lactams but not carbapenem. 
    Subgroup 2df: 
 OXA enzymes having carbapenem-hydrolyzing activities.  
 Grouped  into nine clusters based on  the amino acid homology. 
   subgroup 2e cephalosporinases:  
 Able to hydrolyze extended-spectrum cephalosporins 
 Inhibited by clavulanic acid or tazobactam. 
   Subgroup 2f : 
 Carbapenemases inhibited better by tazobactam than by clavulanic 
acid.  
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Group 3 Metallo β-lactamases (MBLs): 
 Unique in that they have  poor  hydrolytic  capability for  monobactams  
 not inhibited by clavulanic acid or tazobactam.  
 Instead, they are inhibited by metal ion chelators such as EDTA and 
dipicolinic acid 
Group 4 β-lactamases: 
Have been omitted in the present scheme  have yet to be characterised.  
  
 Few unique characteristics of ESBL are as follows: 
a) Mostly class A cephalosporinases and  are plasmid mediated. 
b) More common in Klebsiella species followed by E.coli. 
c) All enzymes are active against cephalothin. 
d) Imipenam and cefoxitin are not hydrolysed. 
e) Comparative activity against  cefotaxime and ceftazidime varies with 
the enzyme. 
f) Inhibition activity by β-lactamase inhibitors can be demonstrated. 
                           
The predisposing  factors for ESBL production are prolonged stay in 
intensive care units, long term use of antibiotics, very severe illness, extensive 
use of third generation cephalosporins, use of life lines and catheters. 
TEM type of ESBLs are the derivatives of TEM-1 and TEM -2. TEM-1 
was first discovered in a  patient called Temonieria and hence named as TEM.  
35 
 
More than 100 types of TEM ESBLs have been  described. TEM-1,2,13 are 
not ESBLs. 
SHV was named so because they are sulfhydryl variable. They are the 
most commonly found type of ESBL in the clinical isolates. It was first 
isolated from Klebsiella ozaenae in 1983. More than 50 types have been 
reported so  far. 
CTX-M are ESBLs which have tendency to hydrolyse cefotaxime more 
than  ceftazidime and also hydrolyse cefepime with more efficiency. More 
than 113 types have been described.  
OXA-β lactamases  have the ability to hydrolyse oxacillin and 
cloxacillin. The other types of ESBL includes PER1-2, VEB-1-2, GES, SFO , 
IBC etc.  
Shashi Gandhi et al (2013) in their study reported that  52.9% of  E.coli 
and 50% in Klebsiella pneumoniae  isolates produced ESBL.47 
Battacharjee A et al (2008) and NNPD/AIIMS/NF (2004)  studies 
showed that one third of E.coli and Kebsiella which are the most common 
isolates causing  neonatal sepsis in India   produced ESBL  both in  hospital  
as well as community settings and had  high mortality rates.48,84 
Recent reports describe ESBLs a global threat to health (Pitout and 
Laupland, 2008) and the Infectious Disease Society of America  has listed  the 
ESBL producing Enterobacteriaceae as one of the six  problematic drug-
resistant   pathogens and reported the urgent need for newer and more 
effective therapeutics.49 
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TREATMENT: 
Indications for initiating  antimicrobial therapy  in neonates  include   
presence of ≥3 risk factors, foul smelling liquor, proven sepsis and  high 
degree of suspicion14. Empirical treatment  is usually based on the prevalent  
etiological agents of that place  and the  probable source of infection which 
can  be modified depending on  the susceptibility reports.  
           Third  generation  cephalosporins  have good CSF penetration and 
traditionally have excellent  activity against Gram negative bacteria. The 
reluctance to promote them as first line drugs is attributed to their  high 
susceptibility  to the ESBLs and significant  association  with repressor 
mutations. Antibiotics like piperacillin/tazobactam or methicillin/vancomycin 
are preferred over them  in a place with high prevalence  of resistance due to 
ESBL producing strains. 
           Reserve antibiotics like monobactams and carbapenems should be  
used only where sensitivity of the bacterial  isolate warrants its use.  Adjunct 
therapy includes supportive care, exchange transfusion, intravenous 
immunoglobulin administration.  Treatment with granulocyte-monocyte 
colony stimulating factor is under experimental study at present.   
           The treatment regimen is undergoing constant re-evaluation to give the 
most effective outcome. Further there cannot be a single recommendation of 
the anti-biotic regime for all settings as the choice of antibiotic is influenced 
by the microbial flora in  the given setting and its susceptibility pattern. At 
present good infection control and more research for the development of 
newer antibiotics  are the two potential domains which determine the outcome 
of sepsis in future.                                                    
  
 
 
 
 
 
 
 
 
 
 
 
MATERIALS & METHODS 
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MATERIALS AND METHODS 
This prospective study was conducted on 200 neonates admitted with 
signs and symptoms of sepsis in the Neonatal Intensive Care Unit at 
Coimbatore Medical College Hospital, Coimbatore over a period of 11 months 
from June 2014 to April 2015. 
The approval for this study was obtained from the ethical committee 
prior to its conduct. Informed consent was obtained from the parents/ guardian 
of the neonate. 
Inclusion criteria for the study subjects included: 
Neonates who completed 32 weeks of gestation 
Presence of ≥3 signs and symptoms of sepsis like refusal of feeds,          
 irritability, fever/ hypothermia, vomiting,  abdominal distension, respiratory 
distress, icterus, convulsions etc. 
Exclusion criteria included: 
                                  Birth weight < 2000 gm  
                                  Presence of congenital anomaly 
                                  Those who underwent surgery 
                                  Suspected metabolic disorder. 
The name, age, sex, address, date and time  of birth, mode of delivery, 
place of birth,  date of admission,  inpatient number and a detailed clinical 
history were noted.  A thorough head to foot examination including general 
examination and systemic  examination was carried out. 
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BLOOD COLLECTION:        
For collection of blood, the skin at the venepuncture site was 
meticulously  prepared by thoroughly cleaning with 70% ethyl alcohol and 
then by povidone -iodine. These bactericidal agents were applied in concentric 
circles  moving outwards from the centre. To avoid the possible irritation of 
iodine it was wiped off with alcohol. The skin was then allowed to dry for 1 
minute  before the blood was withdrawn.  
           Two ml of blood was withdrawn aseptically. 1ml of the blood sample 
collected was inoculated into the blood culture bottle containing 10 ml of 
Brain- Heart infusion broth for culture. The remaining part of the blood was 
transferred to the vial with clot activator to perform the serological tests CRP 
and Pro-calcitonin. 
BLOOD CULTURE: 
The brain heart infusion broth with inoculated blood was incubated 
aerobically at 37°C. It was routinely inspected twice a day for signs of 
bacterial growth like uniform / subsurface turbidity, hemolysis, coagulation of 
the broth, surface pellicle, floccular deposit on the surface and gas production 
consecutively for 14 days. A subculture was done after 48 hours of incubation 
on Blood agar, Chocolate agar and Mac conkey agar. 
The isolates were identified as per the standard procedure by studying 
the colony morphology, performing  Gram staining, motility  and  biochemical 
reactions with suitable controls.50,51,52 
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 GRAM STAIN:   
A  smear was prepared from  18-24 hour old colony from the agar 
plate. After air drying and heat fixation,  Gram staining was done  using 1% 
methyl violet as primary stain, acetone as decolouriser and dilute carbol 
fushcin as counterstain. Gram reaction, shape and arrangement of the bacteria 
were observed. 
MOTILITY: 
A hanging drop was prepared from the saline suspension of the colony 
and observed. The edge of the drop was focussed under high power to observe 
for the motility of the bacteria.    
CATALASE TEST: 
It is done to determine the ability of the organism to produce catalase  
which splits hydrogen peroxide into oxygen and water. The release of oxygen 
produces brisk effervescence.  With a sterile  glass  rod,  a  colony of the test 
organism  was taken and immersed into the 3% hydrogen peroxide solution in 
a sterile test tube. Brisk effervescence indicated a positive reaction. 
OXIDASE TEST: 
This test is done to determine the presence of bacterial cytochrome 
oxidase. Few drops of freshly prepared oxidase reagent (tetra methyl p-
phenylene diamine dihydro chloride) which acts as an artificial electron 
acceptor was placed in  filter paper strips, dried and stored in  dark container. 
Appearance of  dark purple colour due to indophenol formation  when  the 
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colony was smeared  over the moistened filter paper within 10 seconds was 
considered positive. 
COAGULASE TEST51: 
This test differentiates Staphylococcus aureus from CoNS.  
SLIDE COAGULASE TEST:  
The test organism was emulsified in a drop of saline kept on two  
circles on a clean slide  to form a smooth milky suspension. One was kept as 
control and in the  other circle plasma was added with a flamed and cooled 
straight inoculating wire. Coarse clumping  visible within 10 seconds 
indicated a positive reaction. 
TUBE COAGULASE TEST: 
Few colonies of test organism was emulsified  in 0.5 ml of undiluted 
plasma and incubated at 35-37°C  at ambient air. Tubes were  examined at 1, 2 
and 4 hours for clot formation. If negative at 4 hours, the tube was reincubated 
at  room temperature overnight and checked again for clot formation. Any 
degree of clot formation was considered positive. 
TEST FOR INDOLE PRODUCTION:  
This test is used to identify organisms that produce the enzyme 
tryptophanase which hydrolyses tryptophan to pyruvate, ammonia and indole.          
1 drop of 24 hour BHI broth culture was inoculated in tryptophane broth and 
incubated at 37° C. After 48 hours 1 ml of xylene was added and vigorously 
shaken. Then 0.5 ml of Ehrlich’s reagent was added along the sides of the 
tube. Appearance of pink coloured ring indicated a positive reaction.   
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METHYL RED TEST (MR TEST): 
This test is used to determine the ability of the organism to produce and 
maintain stable acid end product from glucose fermentation. A drop of 24 
hour BHI broth culture was inoculated in 5ml of MR-VP broth and incubated 
for 48 hours after which 5 drops of methyl red reagent was added. Appearance 
of  red colour indicated a positive reaction. 
VOGES –PROSKAUER TEST (VP test): 
VP test is used to determine the ability of the organism to produce 
acetoin by glucose fermentation. The organism isolated from primary culture 
plate was inoculated in MR-VP broth and incubated for 48 hours at 37° C. To 
1ml of the inoculated broth 0.6 ml of alpha –naphthol and 0.2 ml of 40% KOH 
were added. A positive test is indicated by the development of red colour as a 
result of acetoin formation. 
UREASE TEST: 
The organisms ability to produce urease which hydrolyses urea into 
ammonia and carbon dioxide is determined by this test. The surface of 
Christensen’s urea agar slant was inoculated with a well isolated colony and 
incubated at 37°C overnight. Purple pink colour formation indicated a positive 
reaction. 
CITRATE UTILISATION TEST: 
This test is used to identify the organisms using citrate as a sole source 
carbon and inorganic ammonium salt as sole source of nitrogen. Simmons 
citrate medium was inoculated with a well isolated colony and incubated 
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overnight  at 37°C. Growth on the medium with change in colour of the 
indicator from green to blue was considered positive. Absence of growth was 
considered negative. 
TRIPLE SUGAR IRON TEST (TSI): 
With a straight inoculation wire top of a well isolated colony was 
touched  and inoculated first by stabbing through the centre of the medium to 
the bottom and then  streaking the surface of agar slant. It was then incubated 
at 37°C overnight and interpreted as follows: 
Acid slant/acid butt (A/A) : Glucose, sucrose and/or lactose fermenter. 
Alkaline slant/acid butt (K/A) : Only glucose fermenter 
Alkaline slant/no change (K/NC): Glucose, sucrose and lactose non 
utiliser. 
Black precipitate in butt: Production of H2S. 
Bubbles/ Cracks in the medium: Gas production. 
CARBOHYDRATE FERMENTATION TEST: 
This test is used to determine the ability of the organism to ferment a 
specific carbohydrate incorporated in a basal medium, produce acid and gas.  
Basal medium with 1% of individual sugar and bromothymol blue as indicator 
was inoculated with the culture isolate and incubated at 37° C for 24 hours. A 
positive test was shown by yellow discolouration of the medium due to acid 
production. 
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MODIFIED HUGH AND LEIFSON TEST: 
Semisolid OF medium containing carbohydrate with bromothymol blue 
as indicator were  inoculated in duplicates with 24 hour bacterial colony by 
stabbing to a depth of 1 cm.  One tube was overlaid with sterile liquid paraffin 
to detect fermentation. Both the tubes were incubated at 37° C in ambient air. 
Interpretation:  Organisms producing yellow colour due to acid production in 
both the tubes were considered fermenters  while  those produce acid only in 
the aerobic tube were considered non-fermenters. 
BACITRACIN SUSCEPTIBILITY TEST: 
This test is done to differentiate Group B beta haemolytic Streptococci 
(GBS)  which is resistant to  Bacitracin 0.04 units  placed in a  lawn culture of 
the test organism on 5% sheep blood agar. After  incubation  at 37°C , a  zone 
size >10 mm was considered susceptible. 
CAMP  TEST: 
The Christie, Atkins and Munch-Peterson (CAMP) test differentiates 
S.agalactiae which shows positive CAMP reaction from other Streptococcal 
species. 
The test organism was streaked perpendicular, within 2 mm from the 
streak line of beta lysin producing strain of S.aureus in 5% sheep blood agar 
plate. After overnight incubation a positive reaction was indicated  by an 
arrowhead shaped zone of beta hemolysis where the two streak lines come 
into proximity. The CAMP factor – an extracellular haemolytic diffusible 
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protein produced by S.agalactiae synergistically acting with the beta lysin of 
S.aureus resulted in the enhanced zone of hemolysis. 
 
 BILE-ESCULIN TEST: 
This test is used to determine the ability of the organism to hydrolyse 
esculin to esculetin in the presence of bile. Esculetin reacts with the ferric 
citrate incorporated in the medium to form a black complex. 
           The colony to be tested was inoculated on the slope of BEA and 
incubated overnight at 37°C. Presence of black colour on the slant was 
considered positive. No blackening after 72 hrs of incubation was considered 
negative. 
ANTI-MICROBIAL SUSCEPTIBILTY TESTING51,53:   
           The sensitivity testing was done based on the approach and zone size 
interpretive criteria established for the commonly tested anti-microbial agents 
published in the CLSI M02 series “ Performance Standards for Antimicrobial 
Disc Susceptibility Tests”.    
Inoculum preparation: 
4-5 colonies of the organism were selected from a 24 hour culture plate 
and inoculated into  broth medium. Turbidity was attained after 3-5 hours of 
incubation  which was adjusted to 0.5 McFarland standard. 
Preparation of McFarland Turbidity standard:     Preparation was done  by 
adding 0.05 ml of 1.175% of anhydrous Barium chloride  to 9.95 ml of 1% 
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sulphuric acid   in a test tube.  A  solution with specific optical density was 
obtained ,then  sealed and placed in refrigerator. 
Procedure: 
A sterile swab was  immersed in the prepared bacterial suspension and 
inoculated in Mueller-Hinton Agar plate. Enrichment with 5%  sheep blood 
was done for fastidious organisms like Streptococci. The surface of  MHA 
plate was swabbed in three directions ensuring even and complete distribution 
of the inoculum over the entire plate. Within 15 minutes of inoculation the 
antimicrobial discs were applied using a sterile forceps. 
           The antimicrobial discs used were procured from Himedia. Each disc 
was pressed down to ensure complete contact with the surface of MHA. The 
plates were inverted for incubation to prevent accumulation of moisture on the 
agar surface which would interfere with the interpretation of the test.  
           The plates were incubated at 37° C for 18-24  hours. The zone of 
inhibition was measured  using the zone measuring scale and interpreted 
according to the CLSI standards.  
Phenotypic confirmation of ESBL production: 
           The Gram negative bacterial isolates which were found resistant to 3 rd  
generation cephalosporins were confirmed for the production of Extended 
Spectrum Beta lactamases (ESBL) by  double disc potentiation test  which is 
the phenotypic confirmatory test as per CLSI standards.53 
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Procedure:  
Cefotaxime 30µg disc and cefotaxime plus clavulanic acid combination 
disc (Cefotaxime 30µg and clavulanic acid 10 µg) were placed at a distance of 
20 mm apart on a lawn culture of the suspected ESBL producing strain on 
MHA. Then the plates were incubated at 37°C for 18 hours. Similar procedure 
was followed with Ceftazidime 30 µg disc and Ceftazidime plus clavulanic 
acid combination disc (Ceftazidime 30µg and clavulanic acid 10 µg). 
Interpretation:      
           If the zone size showed ≥5mm increase in diameter for the combination 
disc (with clavulanic acid)  versus the  zone  size when tested alone (only 
cefotaxime or ceftazidime) it  was confirmed as ESBL producer. The increase 
in size was because the clavulanic acid inhibited the betalactamase produced 
by the isolates. 
Estimation of C-reactive Protein: 
           Qualitative and semi-quantitative analysis of CRP were done by using 
CRP Latex kit (Mediclone Biotech Pvt. Ltd.)  
Principle: 
           When a serum sample positive for CRP is mixed with  specially 
selected polystyrene latex particles coated with monospecific anti-human CRP 
antibodies, a distinctly visible agglutination of the latex particles occur. 
Procedure:  
           The latex reagent, positive and negative controls and serum sample 
were brought  to the room temperature. 50 µl of positive control, serum 
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sample and negative control  were placed in separate cells on the slide. After 
adding  1 drop of latex reagent to all 3 cells, the fluid in the cell was mixed 
and spread  to cover the entire area using separate plastic sticks. The slide was 
then  gently rotated back and forth for 2 minutes. At the end of 2 minutes  the 
results were read under bright light. Serum with CRP content of more than 6 
mg/l  showed distinct agglutination. 
Interpretation of the results:  
                Distinct coarse agglutination:  Positive 
               Smooth suspension/No clumps : Negative 
Semi-quantitative analysis: 
Serum samples  showing positive results  in the screening tests  were 
proceeded with the semi-quantitative test. One drop (50 µl)  of 0.9 % saline 
solution  was placed in all  cells of the slide. 50  µl of serum was placed in the 
first cell and mixed well. 50µ l of this mixture was taken and added to the next 
cell and mixed. The procedure was repeated through the remaining cells.  This 
procedure of serial dilution of the serum resulted in  doubling dilutions 
required  for performing semi-quantitative analysis. One drop of  latex reagent 
was added to all the cells and the test was performed as previously said.  
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The results were  interpreted as follows:           
DILUTION SHOWING 
AGGLUTINATION 
CORRESPONDING CRP LEVEL IN 
mg/l 
1:2 12 
1:4 24 
1:8 48 
1:16 96 
1:32 192 
 
The  titre was calculated by taking the lowest dilution which gave 
visible agglutination  and   it was multiplied with the conversion factor 6 to 
get the CRP values in mg/l. 
Eg. If the titre was 1:16, the CRP concentration was calculated as  
16X6= 96 mg/l. 
MEASUREMENT OF SERUM PROCALCITONIN BY ENZYME 
LINKED FLUORESCENT ASSAY METHOD (ELFA): 
This test was performed using VIDAS BRAHMS PCT kit 
(BIOMERIEUX, France). 
 PRINCIPLE: 
           This assay combines the one step immunoassay sandwich method with 
a final  fluorescent detection. The solid phase receptacle (SPR)  serves  as the 
solid phase as well as the pipetting device. The reagents for assay are ready to 
use and pre-dispensed in the sealed reagent strips. 
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All the steps are performed automatically by the instrument. The serum 
sample is transferred into the wells containing anti-procalcitonin antibodies 
labelled with the conjugate , alkaline phosphatase. This sample/conjugate 
mixture is cycled in and out  of the SPR several times. This enables the 
antigen to bind with the antibody  and the conjugate  to form a sandwich. 
Unbound proteins are eliminated during the washing steps. 
The conjugate enzyme catalyses the hydrolysis of the substrate           
(4-methyl- umbelliferyl phosphate) into a fluorescent product (4-methyl – 
umbelliferone), the fluorescence of which is measured at 450 nm. The 
intensity of the fluorescence is proportional to the concentration of the antigen 
present in the sample. 
PROCEDURE:          
For each sample, control, calibrator,  one PCT strip and one PCT SPR 
were used individually  for testing. The volume of the calibrator, control and 
the sample required for performing the test was 200 µl. PCT strips and PCT 
SPR were inserted into the instrument making sure that the colour labels with 
the assay code on the SPR and the reagent strip were matched. 
The assay was initiated immediately. All the steps were performed 
automatically by the instrument. Once the assay was completed, the results 
were analyzed automatically by the computer using two calibration curves 
which are stored by the instrument and the concentrations of procalcitonin 
were expressed in ng/ml. 
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RESULTS AND INTERPRETATION: 
Low risk of sepsis:   <0.5 ng/ml 
High risk of severe sepsis and shock:  ≥0.5ng/ml.  
 
Statistical analysis: Chi-square test and  independent sample T-test 
were used to analyse the markers correlated  with culture positivity.  A   
p-value of <0.05 was considered statistically significant.  
  
  
Figure 1:  Nutrient agar - Golden yellow colonies of Staphylococcus  aureus . 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2:  5% Sheep Blood Agar- Beta hemolytic colonies of                 
Staphylococcus  aureus. 
 
Figure 3:  Mac Conkey agar -Mucoid lactose fermenting colonies of         
Klebsiella pneumoniae. 
 
 
Figure 4: Mac Conkey agar- Lactose fermenting colonies of Escherichia coli. 
  
 
 
 
 
 
 
 
 
 
Figure 5:  5% Sheep Blood Agar- Greyish white colonies of Escherichia coli. 
 
 
 
Figure 6: Mac Conkey agar- Pale pink colonies of Acinetobacter baumannii.  
 
Figure 7: Gram Stain showing Gram positive cocci in clusters.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Gram negative coccobacilli in pairs – Acinetobacter baumannii.  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: Tube coagulase test. 
 
 
 
Figure 10: Biochemical reactions of Escherichia coli. 
PLASMA CONTROL 
TUBE  COAGULASE POSITIVE 
  
 
Figure 11: Positive CAMP Test in Group B Streptococcus showing arrow head 
zone of hemolysis. 
 
 
 
Figure 12: Antimicrobial susceptibility pattern of Klebsiella pneumoniae by disc 
diffusion method. 
 
Figure 13: Antimicrobial susceptibility pattern of Acinetobacter baumannii 
showing resistance to AK, G, CTR, CAZ and CFS. 
 
 
Figure 14: Phenotypic confirmation of ESBL production by double disc 
potentiation test. 
  
 
 
Figure 15: Latex  slide agglutination  test  for  estimation  of  CRP. 
 
 
 
  
  
Figure  16: VIDAS BRAHMS PCT Kit. 
 
 
 
Figure 17: VIDAS automated PCT analyser. 
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RESULTS 
During  this study period 200  neonates with signs and symptoms of 
sepsis admitted in Neonatal intensive care unit, Coimbatore Medical College 
Hospital were analysed.   
           The haematological parameters which serve as useful diagnostic 
markers of sepsis including C-reactive protein, serum procalcitonin levels, 
altered total WBC  and platelet counts were compared with the blood culture 
positivity which still  remains the gold standard in diagnosing sepsis. 
           Among the 200 neonates suspected with sepsis, 153 (76.5%)  had early 
onset and 47 (23.5%) had late onset.(Refer table no:1) 
           The blood culture isolation rate was 30.5% (n=61). The culture proven 
sepsis was seen more in EOS 85.2% (n=52) than LOS 14.7% (n=9).              
(Refer Table no:2 and Chart no:1). 
           The Male: Female ratio of the neonates included in this study was 1.12: 
1.  Culture positivity  showed only a slight rise  in male neonates (31%) than 
females (28%)  which was not much of a difference.   (Refer Table no:3). 
           Out of 200 suspected sepsis, 62.5% (n=125)  were term neonates and 
37.5%  (n=75) were preterm neonates. About two fold increase in culture 
positivity was seen in preterm neonates (44%) when compared to term 
neonates (22.4%).   (Refer Table no:4 and Chart no :2). 
           In this study 99 neonates were of LBW (<2500 gm) and 101 neonates 
were of normal birth weight. Among the  LBW neonates  culture isolation 
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(n=34)  was high  34.3%  when compared to the normal birth weight neonate  
with 26.7%. (Refer Table no:5 and Chart no :3) 
In this study there was no significant difference in  rate of  culture 
isolation among the neonates   based on the parity of the mother.  The 
percentage of culture proven sepsis was observed more in extramural 
admission (62.3%) when compared to intramural admission (37.7%). (Refer 
Table no:6) 
           Among the 200 suspected cases of neonatal  sepsis, 93 were delivered 
by normal vaginal delivery (NVD), 71 by lower section caesarean section 
(LSCS) and 36 by assisted vaginal delivery (AVD). About two fold raise in 
culture positivity was noticed among the neonates delivered by AVD (50%) in  
comparison  to those delivered by  NVD (29%) and LSCS (22%). (Refer 
Table no:7 and Chart no:4 ). 
           Gram negative organisms constituted the majority of the  culture 
isolates  contributing  to 70.5% when compared to the Gram positive isolates 
(29.5%). (Refer table no:8 ).  Klebsiella pneumoniae (54.1%) was found to be 
the most common GNB isolate followed by Acinetobacter baumannii (9.8%) 
and  Escherichia coli (6.5%).   Among the Gram positive  isolate (13.1%) 
Staphylococcus aureus was the most frequent organism  followed by 
Coagulase negative Staphylococci (9.8%) whereas both Group B Streptococci   
and  Enterococcus faecalis constituted only  3.27%. (Refer table no:9 and 
Chart no:5)  
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The most frequent isolate in case of both EOS and LOS was found to 
be Klebsiella pneumoniae followed by Staphylococcus aureus(Refer table:10). 
           In  the present study, the antimicrobial susceptibility  pattern revealed  
100% sensitivity to Vancomycin, Linezolid and Teicoplanin in  all the Gram 
positive isolates. Amikacin was sensitive in 80% of  S.aureus, 66.6% of 
CoNS. Gentamycin showed moderate sensitivity (50-65%)  among the  Gram 
positive isolates. (Refer table no: 10 &11 and Chart no:6)   
           Third generation cephalosporins  had  sensitivity of  80%  among  
S.aureus  , 83.3% among CoNS and 100%  among  GBS. Cefepime showed  
sensitivity of 87.5% in S.aureus and 83.3% in CoNS. (Refer table no:10 & 11) 
In the predominant  Gram negative isolate of this study Klebsiella 
pneumoniae,  Imepenem and Tigecycline were found to have the highest 
sensitivity (100%) , followed by Piperacillin–tazobactam  (94% ), 
Cefoperazone – sulbactam (91%). Out of 43 Gram negative isolates, 
resistance to third generation cephalosporins (cefotaxime, ceftriaxone & 
ceftazidime)  was  predominantly seen in Klebsiella pneumoniae followed by  
E.coli and A.baumannii. (Refer table no :12 and Chart no:6 ) 
           In the present study,   phenotypic confirmation of  Extended Spectrum 
Beta lactamase production done by double disc diffusion method confirmed 
ESBL positivity in 12 K.pneumoniae (36.5%) and 2 E.coli (50%) isolates.  
(Refer table no :13 and Chart no:7  )  
Among the 200 neonates with suspected sepsis,  altered WBC counts 
(<5000 or >20000 cells/cu.mm) were noticed in 31 neonates among which 9 
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of them had culture proven sepsis.  It showed the lowest  sensitivity of  14.7%  
when compared to other markers and the specificity was found to be 84% (p-
0.015). The positive predictive value and negative predictive values were 29% 
and 69.23% respectively. (Refer  table no:14 &18 and Chart no:10  ). 
           In this study, reduced platelet counts (1,50,000/cu.mm) were noticed in 
96 neonates and culture positivity was seen in 23  of them. Thrombocytopenia 
showed 37.7%  sensitivity and 47.5% specificity with a positive predictive 
value and negative predictive value of 23.9% and 63.4% respectively            
(p-0.096). (Refer table no: 15 &18 and Chart no:10 ) 
           The serum samples of the neonates tested for C-reactive protein  using 
latex agglutination test  were positive in 87 neonates  (43.5%) of which 39 
neonates had culture proven sepsis. The sensitivity of CRP was 63.9%  and   
the specificity was 65.46% (p-0.389). The positive and negative predictive 
values were found to be 44.8 % and 80.5 % respectively.(Refer table no :16,18 
and Chart no:8,10 )  
The serum PCT levels of the neonates  were  detected by Enzyme 
linked fluorescent assay (ELFA)  in this study.   Elevated PCT  levels  
(>0.5ng/ml)  were found  in 74 (37%)  neonates among which  53 (71.6%) of 
them had culture proven sepsis.  PCT had the highest  sensitivity  and 
specificity of 86.88% and  90.07% respectively in comparison with the other 
parameters analysed in this study (p<0.001). The positive predictive value was 
found to be 71.6% and the negative predictive value was 93.6%. (Refer table 
no:  17,18 and Chart no:9,10)                                                               
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TABLE NO. 1 
DISTRIBUTION BASED ON THE ONSET OF SEPSIS AMONG 
SUSPECTED CASES. 
   
Onset of sepsis No. of cases(n=200) Percentage 
EOS 153 76.5% 
LOS 47 23.5% 
             
 
TABLE NO. 2 
DISTRIBUTION BASED ON THE ONSET OF SEPSIS AMONG 
CULTURE PROVEN SEPSIS. 
Onset of sepsis 
No. of culture proven 
cases  (n=61) 
Percentage  
EOS 52 85.2% 
LOS 9 14.7% 
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TABLE NO. 3 
GENDER DISTRIBUTION OF THE CASES. 
 
TABLE NO. 4 
DISTRIBUTION BASED ON MATURITY OF THE NEONATE. 
Maturity 
Suspected sepsis 
(n=200) 
Culture proven 
sepsis  (n=61) 
Percentage  
Preterm  (32-36 wks) 75 33 44% 
Term  (>36 wks) 125 28 22.4% 
 
                                                
  
Sex 
Suspected sepsis 
(n=200) 
Culture  proven 
sepsis (n=61) 
Percentage  
 
MALE 
 
106 
 
33 
 
31% 
 
FEMALE 
 
94 
 
28 
 
28% 
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TABLE NO. 5 
COMPARISON OF SEPSIS BASED ON BIRTH WEIGHT. 
Birth weight 
Total no. of cases 
(n=200) 
Culture  proven 
sepsis  (n=61) 
Percentage 
≥ 2500 gm 101 27 26.7% 
<2500 gm 99 34 34.3% 
 
  
TABLE NO. 6 
OUTCOME OF SEPSIS BASED ON THE PARITY OF MOTHER AND 
PLACE OF BIRTH. 
Parameter Suspected  sepsis  
Culture proven 
sepsis 
Percentage 
Primigravida 96 30 49.2% 
Multigravida 104 31 50.8% 
Intramural 86 23 37.7% 
Extramural 114 38 62.3% 
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TABLE NO. 7 
DISTRIBUTION BASED ON MODE OF DELIVERY. 
Mode of delivery No. of cases 
(n=200) 
Culture positivity 
(n=61) 
Percentage 
NVD 93 29 31.2% 
AVD 36 18 50% 
LSCS 71 16 22.5% 
 
 
 
TABLE NO. 8 
DISTRIBUTION OF THE ISOLATES BASED ON GRAM REACTION 
Gram reaction 
No. of isolates 
(n=61) 
EOS LOS 
Gram positive cocci 18(29.5%) 15(83.3%) 3(16.6%) 
Gram negative  bacilli 43(70.5%) 37(86.1%) 6(13.9%) 
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TABLE NO. 9 
DISTRIBUTION OF THE CULTURE ISOLATES 
Name of the isolate 
Number 
(n=61) 
EOS 
(n=52) 
LOS 
(n=9) 
Klebsiella pneumoniae 33 (54.1%) 28  (53.8%) 5(55.6%) 
Staphylococcus aureus 8  (13.1%) 7 (13.46%) 1(11.1%) 
Acinetobacter baumannii 6  (9.8%) 5 (9.61%) 1(11.1%) 
CoNS 6  (9.8%) 6 (11.53%) - 
Escherichia coli 4  (6.5%) 4 (7.7%) - 
Group B Streptococci 2  (3.27%) 1 (1.9%) 1(11.1%) 
Enterococcus faecalis 2  (3.27%) 1 (1.9%) 1(11.1%) 
 
TABLE NO. 10 
ANTIBIOTIC SUSCEPTIBILITY PATTERN OF S.aureus & CoNS 
DRUG S.aureus (n=8) CoNS (n=6) 
Amikacin 6(80%) 4(66.6%) 
Ampicillin 1(12.5%) Nil 
AMC 7(87.5%) 6(100%) 
Cefotaxime 6(80%) 5(83.3%) 
Cefepime 7(87.5%) 5(83.3%) 
Gentamicin 5(62.5%) 4(66.6%) 
Vancomycin 8(100%) 6(100%) 
Linezolid 8(100%) 6(100%) 
Teicoplanin 8(100%) 6(100%) 
 
AMC- Amoxicillin plus clavulanic acid 
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TABLE NO. 11 
ANTIBIOTIC SUSCEPTIBILITY PATTERN OF GBS AND E.faecalis 
Name of the 
antibiotic 
Sensitivity for GBS 
(n=2) 
Sensitivity for E.faecalis 
(n=2) 
Ampicillin 2(100%) 1(50%) 
AMC 2(100%) 1(50%) 
Cefotaxime 2(100%) NT 
Ceftriaxone 2(100%) NT 
Gentamicin 1(50%) NT 
High level gentamicin NT 1 (50%) 
Linezolid 2(100%) 2(100%) 
Vancomycin 2(100%) 2(100%) 
Teicoplanin 2(100%) 2(100%) 
 
AMC- Amoxicillin plus clavulanic acid 
NT- not tested 
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TABLE NO. 12 
ANTIBIOTIC SUSCEPTIBILITY PATTERN OF GRAM NEGATIVE 
ISOLATES 
Name of the 
antibiotic 
K.pneumoniae 
(n=33) 
A.baumannii 
(n=6) 
E.coli 
(n=4) 
Amikacin 24(72.7%) 4(66.6%) 3(75%) 
Gentamicin 21(63.6%) 3(50%) 3(75%) 
Cefotaxime 18(54.5%) 4(66.6%) 2(50%) 
Ceftriaxone 19(57.6%) 4(66.6%) 2(50%) 
Ceftazidime 17(51.5%) 5(83.3%) 2(50%) 
Cefepime 28(84.8%) 4(66.6%) 3(75%) 
CFS 30(91%) 4(66.6%) 4(100%) 
PIT 31(94%) 5(83.3%) 4(100%) 
Imepenem 33(100%) 6(100%) 4(100%) 
Tigecycline 33(100%) 6(100%) 4(100%) 
 
CFS- Cefaperazone plus sulbactam 
PIT- Piperacillin plus tazobactam 
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TABLE NO. 13 
ESBL PRODUCTION AMONG THE GRAM NEGATIVE ISOLATES 
Name of the 
isolate 
No.of isolates ESBL positive Percentage 
K. pneumoniae 33 12 36.5% 
E.coli 4 2 50% 
 
 
TABLE NO. 14 
CORRELATION BETWEEN TOTAL WBC COUNT &               
BLOOD CULTURE 
Total WBC 
count 
No. of cases Proven sepsis Percentage 
Abnormal 31 9 29.03% 
Normal 169 52 30.76% 
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TABLE NO. 15 
CORRELATION BETWEEN PLATELET COUNT & BLOOD 
CULTURE 
Platelet count 
No. of cases 
(n=200) 
Proven sepsis Percentage 
Reduced 96 23 23.9% 
Normal 104 38 36.5% 
 
 
 
TABLE NO. 16 
CORRELATION BETWEEN CRP AND BLOOD CULTURE 
CRP 
Total no. of 
cases 
Proven sepsis Percentage 
Elevated 87 39 44.8% 
Normal 113 22 19.4% 
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TABLE NO. 17 
CORRELATION BETWEEN SERUM PCT AND BLOOD CULTURE 
Serum PCT 
Total no. of 
cases 
Culture proven Percentage 
Positive 74 53 71.6% 
Negative 126 8 6.3% 
 
TABLE NO. 18 
STATISTICAL ANALYSIS OF SEPSIS MARKERS 
 
Marker 
 
Sensitivity 
 
Specificity 
 
PPV 
 
NPV 
Altered WBC count 14.7% 84% 29% 69.23% 
Thrombocytopenia 37.7% 47.5% 23.9% 63.4% 
CRP 63.9% 65.46% 44.8% 80.5% 
PCT 86.88% 90.07% 71.6% 93.6% 
 PPV- positive predictive value             NPV- negative predictive value 
 
 
  
  
 
 
 
 
 
 
 
 
 
CHART NO: 1.  DISTRIBUTION BASED ON THE ONSET OF SEPSIS 
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DISCUSSION 
Neonatal  sepsis  with  its  high  mortality  and  morbidity  despite  the  
use  of  higher  antibiotics  and  advanced  supportive  care  still  remains  a  
diagnostic  and  treatment  challenge  to  the  health  care  providers.  An  early  
and  prompt  diagnosis  helps  in  the  institution  of  therapy  at  the  earliest  
and  also  prevents  the  unnecessary  use  of  antibiotics  thereby  keeping  the  
emergence  of  drug  resistance  in  check. 
In  the  present  study  200  neonates  with  signs  and  symptoms  of  
sepsis  were  investigated  and 61 (30.5%)  were  found to be culture  positive.  
This  isolation  rate (30.5%)  is comparable  with  the  30%  isolation  by        
E Malakan  Rad  and  N Momtazmanesh  et al (2004),  26%  isolation  by  
Ahmed  et  al  (2002),  40%  by  Mahabatra  et  al  (2002)  and  Bhattarjee      
et  al  (2008).54,55,56,48 
A  lower  rate  of  culture  isolation  was  recorded  by  Shahsanam  
Gheibi  et al (2008)  with  11%,  Ziba  Mosayebi  et  al  (2003)  with  13%    
and  Baltimore et  al  (2001),  Gladstone  et al (1990)  and  Sharma  et al 
(1993)  with  20%.3,16,58,59   Much  higher  rates  of  culture  positivity  of  
about  41.6%  by  Zakaria  et al (2010),  51%  by  Karthikeyan  and  
Premkumar  (2001)  and  64%  by  Tallur  et  al  (2001)  were  also  
reported.3,61,62 
The  variation  in  the  rate  of  isolation  can  be  attributed  to  the  fact  
that  the  incidence  of  neonatal  sepsis  varies  from  place  to  place  under  
the  influence  of  various  factors  like  gestational  age,  birth  weight  of  the  
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neonate,  maternal  nutrition,  perinatal  care,  health  care  facilities  etc.  It  
also  varies  accordingly  with  prior  administration  of  antibiotics  to  the  
mother  before  delivery  or  to  the  neonate  before  collecting  blood  sample.  
Also  infection  by  anaerobes   may  contribute  to  this  disparity. 
Though  bacteria  are  the  most  common  agents  implicated  to  cause  
sepsis,  organisms  like  adeno virus, enterovirus,  rubella  and coxsackie  
viruses,  Toxoplasma  and  Candida  species  which  are  the  other  causative  
organisms  of    sepsis  in  neonates  may  add  up  to   cause  the    discrepancy  
in  rate  of  culture  isolation. 
The  male:female  ratio  of  the  study  population  was  1.12:1.  There  
is  a  slight  male  preponderance  for  culture  positivity  in  the  present  study  
which  is  comparable  to  the  other  studies  by  Shreshtha  NJ  et  al (2011),  
Begum  et  al (2012) , Mutulu  et  al  (2011)  and  Naher  H.S  and  Khamael  
A.B  (2013).63,64,65,66 
The  incidence  of  early  onset  sepsis  was  more  when  compared  to  
the  late  onset  sepsis.  It  is  consistent  with  the  studies  by  Movahedian  
AH  et  al (2006),  Rasul  C.H  et  al (2007), Waseem  R  et  al (1996),  
Aletayab  et  al  (2011)  and  Al-Shamahy  et  al  (2012).67,68,69,70,71 
However  increased  LOS  when  compared  to  EOS  has  been  
reported  in  the  studies  done  by  Kayange  N  et  al  (2010),  Aftab  R  &  
Iqbal I (2006), Karambin  MM et al (2011)  and  Shrestha  NJ  et  al  
(2011).72,73,74,63 
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The  lower  incidence  of  LOS  in  this  study  cannot  be  explained  
by a single  factor. Various  changes  that  have  occurred  in  the  recent  years  
in  addition  to  the  increased  awareness  in  prevention  of  sepsis  like  better  
hand hygiene practices, maintaining standard protocols in handling  
intravenous  catheters  and  shorter  duration  of  invasive  ventilation  due  to  
the  use  of  surfactants  could  have  contributed  to  the  decreased  incidence  
of  LOS. 
Culture  proven  sepsis  was  more  common  among  the  preterm  and  
low  birth  weight  babies.  Similar  findings  were  reported  in  various  
studies  including  Dhumal et al (2012), Caserta MT (2013),  Vergnano  et  al  
(2005)  and  Clark  R  et  al  (2004),  Woldu  MA  et  al  (2014)  and   Mutlu  
et  al  (2011).75,76,77,78,65,10 A  very  strong  association  of  culture  proven  
sepsis  (94%) with prematurity was reported by Chauhan Setal B et al  
(2012).29 
LBW  and  preterm  neonates  are  at  high  risk  of  developing  sepsis  
in  comparison  to  a  term  neonate  as  they  are  vulnerable  to  sepsis  due  to  
their  intrinsic  susceptibility  to  infection  owing  to  the  immature  immune  
system  in  addition  to  other  factors  like  prolonged  hospital  stay,  total  
parenteral  nutrition  and  exposure  to  invasive  procedures. 
Further  in  this  study  a  significant  proportion  of  culture  proven  
sepsis  was  found  to  be  associated  with  assisted  vaginal  delivery  using  
instrumental  procedures.  The  risk  of  acquiring  sepsis  was  twofold  more  
common  in  them  than  infants  born  by  LSCS.     
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This finding  is similar to the studies  conducted  by  Woldu  MA  et  al  
(2014)  and  Ogunlesi  TA  &  Ogunfowara  OB  (2010).78,79  Woldu  MA  et  
al  demonstrated  that  the  risk  of  acquiring  sepsis  in  AVD  was   6.2  times  
more  when  compared  to  NVD.78  According  to  Bangi  VA  and  Devi  SS  
(2014)  significant  mortality  was  seen  in  instrument  assisted  deliveries  
owing  to  higher  probability  of  infection  which  is  supported  by  other  
studies  conducted  by  Raghavan  M  et  al  (1992)  and  Maguire  GC  et  al  
(1981).80,81,82 
Though the instruments  used  for  AVD  were  sterilised  appropriately  
disparity  in  the  outcome  could  be  due  to    early  rupture  of  membranes  
and  contamination  from  environment  during  delivery.   
Further  in  the  present  study,  the  rate  of  culture  proven  sepsis  
was  a  little  higher  among  neonates  delivered  by   NVD  when  compared  
to  LSCS. According to Shrestha  P  et  al (2007)  and  Tallur  et  al (2000).93,62 
NVD  showed  higher  rates  of  culture  isolation  than  the  neonates  
delivered  by  LSCS  which  coincides  with  our  study.     
The  foetus  is  at  risk  of  exposure  to  the  colonised  microbial  flora  
in  the  maternal  genital  tract  during  labour.  The  encounter  with  the  
pathogens  during  delivery  in contrast  to  the  sterile  in-utero  environment  
accounts  for  this  high  degree  of  culture  positivity  among  the  neonates  
delivered   by  AVD/NVD  than  LSCS. 
In  the  present  study  culture  proven  sepsis  was  more  common  in  
extramural  admissions  constituting  62.3%  of  culture  positivity.              
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This  finding  goes  in  correlation  with  studies  done  by  Sankar  MJ  et  al  
(2008)  and  the  report  of  National  Neonatal  Perinatal  Database    2002-
200383,84.    Failure  to  adhere  to   the  sterility  precautions   at  the  
peripheral  centres  while  conducting  delivery  makes  the  neonate  prone  
for  infection  with  the  prevailing  hospital  flora  accounting  for  majority  
of  extramural  sepsis.  In  India  Klebsiella  pneumoniae  and  Staphylococcus  
aureus  are  the  common  organisms  associated  with  it. 
Gram  negative  bacilli  (70.5%)  constituted  the  majority  of  isolates  
in  this  study. Similar  pattern  of  culture  isolates  has  been  observed  in  
studies  conducted  by   K.J  Desai  et  al  (2011),  Kumhar  GD  et  al  (2002),  
Aletayeb  SMH  et  al  (2011),  Sundaram  V  et  al  (2009), Mustafa  M  et  al 
(2014) and  National  Neonatal  Perinatal  database  (NNPD)  
(2003).85,86,70,9,87,84 
However  this  is  in  contrast  to  the  findings  reported  in  the  studies  
conducted  in  developed  countries  by Karlowicz  et  al  (2000)  and  
Awoniyi  et  al  (2009)  where  predominant  cause  of  sepsis  were  GBS  and  
CoNS88,89.   Sanghvi  TP  et  al  (1996)  and  Stoll  BJ  et  al  (2002)  also  
reported  the  variation  in  the  etiology  of  neonatal  sepsis  between  
developing  and  developed  countries.90,91 
The  pathogens  most  often  implicated  to  cause  neonatal  sepsis    
not  only  differ  in  geographical  distribution   but  also  change  with  respect  
to  time  even  in  the  same  area  which  can  be  attributed  to  the    
difference  in  living  conditions  according  to   Shrestha  P  et  al    (2007).93 
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The  most  frequent  isolate  in  this  study  was  K.pneumoniae  
(54.1%)  in  both  early  and  late  onset  sepsis  which  is  concordant  with  
the  other  Indian  studies  Kayange  N  et  al  (2010),  National  Neonatal  
Perinatal  Database  (2003),   Kumhar  GD  et  al  (2002)  and  Sriram  R  et  al  
(2011).72,86,92,84 
In  developing  countries Klebsiella  pneumoniae  is  the most  common 
agent associated with  neonatal sepsis.  The  capsular  polysaccharide  and  
lipopolysaccharide  determine  the  virulence  of  Klebsiella  pneumoniae.  
The  genetic  constitution  of  the  lipopolysaccharide  show  wide  variation  
when  compared  to  the  other  Gram  negative  bacteria  which  makes  
K.pneumoniae  highly virulent resisting  the complement  mediated  
opsonisation  &  phagocytosis.     
Staphylococcus  aureus  (13.1%)   was  the  second  common  organism  
isolated  followed  by  Acinetobacter  baumannii  (9.8%)  and    CoNS  (9.8%)   
which  is  in  concordance  with   KJ  Desai  et  al  (2011),   I  Roy  et  al  
(2002),  Sanjay  D  Rathod  et  al  (2012)  where  all  of  them  reported  a  
similar  pattern  of  culture  isolates.85,94.95 
Both  K.pneumoniae  and  S.aureus  are  nosocomial  pathogens  as  
they  tend  to  colonise  the  hospital  environment  as  well  as  health  care  
personnel,  making  these  organisms  the  predominant  cause  of  sepsis. 
Higher  rates  of  E.coli  isolation  has  been  demonsrated  in  the  
studies  done  by  Agarwal  A  et  al  (2015),  Naher  HS  &  Khamael  AB  
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(2013)  and  Mustafa  et  al  (2014).96,66,87 MN  Shah  and  PB  Desai  (2011)    
reported  that  E.coli  was  the  predominant  cause  of  neonatal  sepsis.98   
But  in  studies  done  by  Rahul  Kamble  &  Rajesh  Ovhal  (2015) ,          
Sanjay  D  Rathod  et  al  (2012)  and  Amare  Gebrehiwot  et  al  (2012)    
lower  E.coli  isolation  rates  of  <10%    were  reported   which  is  similar  to  
this  study in which E.coli was isolated from only  4  neonates  (6.5%).99,95,101   
Both  Acinetobacter  and  CoNS  are  commonly  found  in  the  
environment  of  NICU.  Though  they  are  implicated  as  organisms  of  low  
virulence,  significant  rates  of    isolation  in  this  study  can  be  attributed  
to  the  intrinsic  susceptibility  of  the  neonate  due  to  lack  of  effective  
immune  response.  Under  these  circumstances  these  organisms  acquire    
high  pathogenicity  especially  in  premature  neonates.  Long  term  
epidemiological  studies  performed  have  revealed   an  increasing  trend  in      
incidence  of  CoNS    in  the  recent  years.                               
Recent  studies  done by  Van den Hoogen A et al  (2010)  and  
Zakariya  et  al  (2010)  reported   that   Group  B  Streptococci  which  was  
previously  considered  as  a  predominant  organism  associated  with  EOS  
is  now  showing  a  decreasing  tendency.102,3  This    is  concordant  with  the  
present  study  in  which  the  isolation  rate  of  GBS  was  only  3.27%  
(n=2).  Jones  AM  et  al  (2001)  has  reported  that  the  difference  in    
socio-economic  status  and  ethnicity  contribute  to  this  varying  incidence  
of  sepsis  caused  by  GBS.104     
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Isolation  of  Enterococcus  species  has  been  occasionally  reported  
from  various  studies.  In  the  present  study    E.faecalis  (n=2)  accounting  
for  3.27%  of  culture  positivity  was  isolated.  Similarly   lower  isolation  
rates  were  also  seen  in  the  studies  conducted  by  Rao  Pooja  et  al  
(2015)  and  Sanjay  D  Rathod  et  al  (2012).105,95 
Antimicrobial  susceptibility  pattern  play  an  essential  role  in  
effective  management  of  sepsis  in  neonates  and    it  varies  from  place  to  
place.  Sound  knowledge  of  the  pattern  of  antibiotic  sensitivity  in  the  
region  guides  in  the  right  choice  of  prophylactic  antibiotics. 
All  the  Gram  positive  organisms  were  100%  sensitive  to  
Vancomycin,  Linezolid  and  Teicoplanin  which  correlates  with  most  of  
the  studies  including  those  done  by  Rahul  Kamble  &  Rajesh  Ovhal  
(2015),  Mustafa  et  al  (2014),  Sanjay  D  Rathod  et  al  (2012)  and  Mane  
AK  et  al  (2010).99,87,95,106  S.aureus  and  CoNS  were  highly  resistant  to    
Ampicillin  and  Gentamicin  which  correlates  well  with  the  studies  by    
Mustafa M et al (2014), Aletayeb  SMH et al,  Rao  Pooja  et al  (2015).87,70,105 
GBS  showed  100%  sensitivity  to  Ampicillin  which  correlates  with  
most  studies  which  conclude  that  penicillin  resistance  is  yet  to  be  
documented. Though  in vitro  susceptibility  testing  is  not  routinely  
recommended  for  E.faecalis  due  to  intrinsic  resistance,  in  case  of  multi  
-drug  resistant  strains  causing  severe  infections  testing  with  high  level  
Gentamicin  can  be  done.  This  is  in  the  context  of  using  it  as  an  
adjunct  antibiotic  acting  synergistically  with  another  drug  in  combination  
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(vancomycin)  unless  resistance  to  HLG  is  documented.  Resistance  to  
HLG  was  seen  in  one  of  the  two    E.faecalis  isolates    in  this  study51,53. 
Among  the  Gram  negative  isolates,  all  were  highly  susceptible  to  
Imipenem  and  Tigecycline  followed  by  Cefaperazone-sulbactam  and  
Piperacillin  Tazobactam  which  is  similar  to  the  findings  of               
Mustafa  M  et  al  (2014)  and  Waseem  R  et  al  (2005)87,69. 
Acinetobacter  baumannii   showed  higher  degree  of  antibiotic  
resistance  when  compared  to  E.coli  and  Klebsiella  pneumoniae.  But  all  
of  Acinetobacter  isolates  were  susceptible  to  Tigecycline.  Similar  pattern  
of  antibiogram  was  reported  by  Kamble  &  Rajesh  Ovhal  (2015)  and  
Agarwal  A  et  al  (2015)99,96. 
Third  generation  cephalosporins  resistance  (40  to  50%)  were  more  
than  the  resistance  to  aminoglycosides  in  both  K.pneumoniae  and  E.coli  
which  is  concordant  with  the  study  conducted  by  Mutlu  M  et  al  
(2011)65.  Couto  RC  et  al(2007),   Iregbu  et  al  (2006)  and  Sanjay  D  
Rathod  et  al  (2012)  reported  similar  degree  of  resistance  among  third  
generation  cephalosporins103,108,95. Gram  negative  isolates  were  found  to  
have  high  sensitivity  to  Cefepime,  CFS  and  PIT  comparable  to  most  
other  studies. 
ESBL  production  was  seen  in  36.5%  of  K.pneumoniae  and  50%  
of   E.coli  isolates  in  the  present  study.  Similar  findings   were  revealed  
in  the  studies conducted by Kamble & Rajesh Ovhal (2015),                
Mustafa M et al  (2012).99,87  Roy  et  al  (2013)  observed  higher  ESBL  
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production  in  Escherichia coli  than  Klebsiella pneumoniae  like  the  
findings  in  this   study.109 
According  to  Jain  et  al  (2007),  the  selective  pressure  imposed  
due  to  the  extensive  use  of  these  drugs  in  addition  to  high  potential  of  
patient  to  patient  transmission  in  NICU  caused  ESBL  production  in  
these  organisms.110  Various  studies  have  emphasized   routine  testing    for  
ESBL  production  among  the  isolates. 
Blood  culture  not  only  takes  time,  it  is  also  a  complicated  
process  with  low  yield.  The  readily  available  complete  blood  counts  and  
the  leukocyte  differential  assays  have  relatively  low  specificity  for  
diagnosis  and  is  widely  used  as  an  adjunct  to  culture.  There  is  no  
single  reliable  test  for  definitive  diagnosis  as  of  date  and  there  is  a  
continuing  search  for  a  new  marker.   
Altered  WBC  count  in  this  study  was  seen  in    31  neonates  of  
which  9  had  proven  sepsis  with    14.7%  sensitivity  and  84%  specificity.  
This  is  similar  to  the  study  done  by  Khurshid  Anwar  A  and  Sultan  
Mustafa (2000)  where  14%  sensitivity  and  93%  specificity  was  
reported111. 
Though  altered  leucocyte  count  is  a  highly  specific  indicator,  the  
sensitivity  is  very  low  in  diagnosing  sepsis. According to  Casken  H  et  al  
(2003)  there  was  not  much  of  a  significant  difference  in  WBC  counts 
between culture  positive  and  culture  negative  sepsis112.  According to  
Blommendahl J et al. (2002),  Arghyadip  Sahoo  and  Priyanjalee  Banerjee,  
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altered  WBC  count  cannot  be  taken  as  a  reliable  diagnostic  test  for  
sepsis  in  neonates6,113. 
Similar  results  were  reported  in  the  studies  done  by             
Ottolini  MC  et  al  (2003),  Mayuga  WAB  (2005)  and  Priyamvadha  Roy  
et  al  (2014)  in  which  no  significant  correlation  was  found  between  
WBC  counts  and  sepsis.114,115,44 
Reduced  platelet  counts  are  frequently  encountered  in    critically  
ill  neonates  irrespective  of  age  and  maturity.  In  the  present  study  
thrombocytopenia  was  an  important  feature  noted  among  48%  (n=96)  of    
sepsis  suspected  neonates.  It is  in concordance  with  prevalence  of  
thrombocytopenia  in   most  studies    (30%-60%).   
Among  those  with  thrombocytopenia,  23  (23.9%)  were  culture  
positive.  Similar  results  were  observed  by  Arif  SH  et  al  (2012)  and  
Torkaman  et  al  (2009)suggesting  that  though  reduced  platelet  counts  
was  an  important  indicator  in  sepsis  it  is  not  specific  enough  to  be  
used  as  a  sole  indicator.116,117 
In  a  study  conducted  by  Mirza  Sultan  Ahmad  and  Abdul  Waheed  
(2014)  24.7%  of  culture  proven  sepsis  had  thrombocytopenia  which  is  
concordant  with  the  present  study  (23.9%).118 
There  was  no  significant  difference  observed  in  the  incidence  of  
thrombocytopenia  based  on  Gram  positivity  or  negativity  of  the  
organism  in  this  study  which  is  similar  to  a  study  done  by          
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Manzoni  P  et  al  (2009)  to  assess  organism  specific  response  of  platelet  
count  in  neonatal  sepsis.119   
Analysis  of  both  WBC  and  platelet  counts  have  revealed  that  
individual  haematological  findings  should  be  interpreted  with  much  
caution  since  the  haematological  response  may  vary  with  gestational  and  
post-natal  age  according  to  Monroe  BL  et  al  (1977).120  These  findings  
also  vary  with  the  time  interval  of  the  onset  of  sepsis  and  blood  
sampling  as  reported  by  Escobar  GJ  (1999).121  In  addition,  the  influence  
of  the  site  of  sampling  as  the  number  of   arterial  and  venous  leukocytes  
are  less  than  the  capillary  WBC  values  was  reported  in  the  study  done  
by  Philip  AGS  et  al  (1982).122 
C-  reactive  protein  acts  as  a  scavenger  causing  opsonisation  of  
bacteria  and  activation  of  the  complement  system  thereby  facilitating  
phagocytosis  during  inflammatory  response.  CRP  assay,  the  most  
analysed  parameter  for  years  has  higher  likelihood  of  predicting  sepsis  
among  most  other  parameters. 
In  the  present  study,  the  sensitivity  of  CRP  was  63.9%  and  
specificity  was  65.46%.  This  finding  correlates  with  the  studies  done  by    
Sakha  et  al  (2008)  and  Vazzalwar  et  al  (2009)  with  sensitivity  of  
70.4%  and  72%  respectively.123,124 
Boo .N.Y et  al  (2008),  Garland  Suzanne et  al (2003) and  
Sucilathangam  G  et  al (2012)  revealed  lower  sensitivity  patterns    (<55%)  
in    their  studies.125,126,127   But  higher  sensitivity  and  specificity  have  also  
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been  reported  by  Zeeshan  et  al  (2005)  with  82.7%  &  95.9%  and         
Jan  AZ  et  al  (2013)  with  88.36%  &  89.13%  respectively.128,129  An  
intriguing  100%  sensitivity  has  also  been  recorded  in  a  study  done  by  
Nuntnarumit  P  et  al  (2002).130 
The  differences  in  these  studies  may  be  due  to  the  variation    
with  respect  to  the  timing  of  CRP  assay  after  the  clinical  onset  of  
infection  in  addition  to  the  fact  that  all  these  studies  measured  CRP  
quantitatively  with  different  cut-off  points . 
Like  CRP,  procalcitonin  has  been  proposed  as  a  marker  for  
bacterial  sepsis.  The  pro-inflammatory  cytokines  which  play  a  key  role  
in  pathogenesis  trigger  the  secretion  of  procalcitonin.  In  neonates  
elevated  procalcitonin  may  help  in  predicting  sepsis  while  lower  levels  
rule  out  bacterial  sepsis. 
In  the  present  study  PCT  levels  were  remarkably  high  among  
neonates  with  proven  sepsis.  This  finding  is  comparable  to  the  studies  
done  by Monneret et  al  (1997)  and  Yadolla  Zahedpasha  et  al  (2009).131,41 
Among  the  200  neonates  of  suspected  sepsis  PCT  was  elevated  
in  74   neonates  whereas   CRP  was  elevated  in  87.  Out  of  61  culture  
proven  sepsis  elevated  serum  PCT  was  seen  in  53  (71.6%)  cases  while  
elevated  CRP  was  noticed  in  39  (63.9%)  cases.   In  our  study  the  
sensisitivity  and  specificity  of  PCT  was    86.88%    and  90.07%    when  
compared  to  that  of  CRP  (63.9%  and  65.46%).  Sucilathangam  G  et  al  
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(2012)  also  reported  higher  sensitivity  and  specificity  of  PCT  in  
detecting  sepsis  in  correlation  with  CRP.127 
A  study  conducted  by  Ballot  DE  et  al  (2004)  which  revealed  
89.5%  sensitivity  and  negative  predictive  value  of    95%  for  serum  PCT    
is  comparable  to  the  findings  in  our  study132.  According  to  them  though  
PCT  could  not  be  relied  as  a  sole  marker  of  sepsis,    it  plays  a  vital  
role  in  sepsis  workup  and  with  its  high  negative  predictivity,  lower  
levels  of  PCT  rules  out  sepsis. 
The  reliability  of  PCT   in  28  neontes  with  early  onset  sepsis  was  
studied  by  Chisea  et  al  (1998)  and  found  that  the  sensitivity,  specificity,  
PPV  and    NPV  were  92.6%,  97.5%,  94.3%  and  96.8%  respectively  
which    correlates  with  the  findings  of  the  present  study133.  Though  PCT  
was  elevated  in  24  of  them  at  the  time  of  presentation,  significant  rise  
in  CRP  levels  were  seen  in  only  half  of  them  with  elevated  PCT.  
Similar  study  done  by  Hatherill  M  et  al  (1999)  also  revealed  higher  
sensitivity  &  specificity  of  PCT  in  diagnosing  early  onset  sepsis.134 
The  analysis  in  a  study  by  Sakha  K  et  al  (2008)  revealed    that  
CRP  was  a  sensitive  marker(70.4%)    than  PCT  (66.7%)  in  diagnosing  
sepsis.123 However  most of the studies  including  those  of    Carol  ED  et  al  
(2002)  and  Koksal  N  et  al  (2007)  emphasized    the  investigative  role  of  
PCT  in  diagnosing  neonatal  sepsis  rather  than  CRP  and  concluded    that  
PCT  was  more  sensitive  compared  to    CRP  which  correlates  with  our  
study.42,57 
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The    sensitivity  of  CRP  is  negated  during  the  initial  48  hours  of  
infection since there is only a slow rise. Further elevated  CRP  concentrations  
in  conditions  other  than  sepsis  like  PROM  and  meconium  aspiration  are  
found  to  affect  its  specificity  as  well.     
In  this  study,  the  sepsis  indicators  which  were  analysed  and  
correlated  with  blood  culture  showed  that  WBC  counts  had  the  least  
sensitivity  and  thrombocytopenia  was  the  least  specific  indicator.    Serum  
PCT  showed  the  highest  specificity  and  sensitivity  than  CRP    &  others. 
Hence  PCT  can  be  used  as  a  sensitive  tool  in  diagnosing ,  
following  the  course  of  treatment  and  predicting  the  prognosis  in  
neonatal  sepsis.  It  can  be  used  to  differentiate  bacterial  from  viral  
infections as  it  is  specific  for  bacterial  sepsis.  Also it  assists  in  
diagnosing  sepsis  early  on  the  day  of  admission  itself  and  also  prevents  
inadvertent  use  of  antibiotics  thereby  reducing  further  emergence  of  
drug  resistant  strains. 
Inspite  of  its  essential  role in  sepsis,  with  all  the  added  
advantages  PCT  still  cannot  be  relied  as  a  sole  marker.  A  much  
detailed  intervention  and  multiple  large  scale  cross  sectional  studies  with  
a  much  higher  sample  size  should  be  performed  to  further  confirm  
these  findings  to  make  serum  PCT  “the  diagnostic  marker”  of  sepsis. 
Until  then  the  isolation  of  the  causative  organism  by  culture  
occupies  the  centre  stage  in  diagnosing  sepsis.     
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SUMMARY 
 In  this  study  200  neonates  with  clinical  suspicion  of  sepsis  admitted  
in  NICU,  Coimbatore  Medical  College  were  studied  over  a  period  of  
11  months  from  June  2014  to  April  2015. 
 One  hundred  and  six  male  babies  and  ninety  four  female  babies  
were  included  in  this  study. 
 Early onset sepsis (76.5%) was more common than late onset sepsis  
(23.5%) 
 Culture  proven  sepsis  was  seen  in  30.5%  of  the  neonates. 
 Twofold  rise  in  culture  positivity  was  seen  in  preterm  (44%)  than  in  
term  neonates  (22.4%).   
 Significant  increase  in  culture  proven  sepsis  was  noted  among  
neonates  of  low  birth  weight  than  those  with  normal  birth  weight. 
 Extramural  admissions  (62.3%)  showed  higher  rates  of  culture  
positivity  than  intramural  admissions(37.7%). 
 The  incidence  of  culture  proven  sepsis  was  significantly  high  among  
neonates  delivered  by  AVD  (50%)  in  comparison  with  those  
delivered  by  NVD  (29%)  and  LSCS  (22%). 
 Gram  negative  bacilli  constituted  the  majority  of  the  culture  isolates  
(70.5%). Klebsiella  pneumoniae  (54.1%)  was  the  most  frequent  isolate  
followed  by  Staphylococcus  aureus(13.1%),  Acinetobacter baumannii 
(9.8%), CoNS  (9.8%), Escherichia coli (6.5%), Group B Streptococci 
(3.27%) and Enterococcus faecalis (3.27%). 
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 Klebsiella  pneumoniae  was  the  commonest  causative  organism  of  
both  EOS  and  LOS. 
 All  Gram  positive  cocci  were  100%  susceptible  to  Vancomycin,  
Linezolid  and  Teicoplanin.  Sensitivity  to  Amikacin  was  high  when  
compared  to  Gentamicin.  High  level  aminoglycoside  resistance  was  
seen  in  50%  of  E.faecalis  isolates . 
 All  Gram  negative  isolates  were  100%  sensitive  to  Imepenem  and  
Tigecycline.  Susceptibility  to  CFS,  PIT  and  Cefepime  were  
remarkably  high  when  compared  to  aminoglycosides  and  3rd  
generation  cephalosporins.   
 Phenotypic  confirmation  of  ESBL  production  by  double  disc  
potentiation  method  confirmed  ESBL  positivity  in  50%  of  E.coli  and  
36.5%  of  K.pneumoniae  isolates. 
 Though  total  WBC  counts  had  a  marked  specificity  ,  it  showed  
lowest  sensitivity  among  all  the  sepsis  markers  analysed  in  this  
study .   
 Thrombocytopenia  was  found  to  be  a  non-specific  indicator  compared  
to  other  markers. 
 Serum  PCT  was  a  more  reliable  marker  than  CRP  in  the  context  of  
early  diagnosis  and  predicting  prognosis  as  PCT  showed  the  highest  
sensitivity  and  specificity  among  all  other  markers  which  were  
correlated  with  blood  culture  in  this  study. 
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CONCLUSION 
In  this  study  the  risk  factors  commonly  associated  with  neonatal  
sepsis were   found  to  be  prematuriy,  LBW,  instrumental  delivery  (AVD).    
EOS was more common than LOS. Gram negative sepsis  was  predominantly  
seen  and  were    highly  susceptible  to  Imipenem  and  Tigecycline. 
Procalcitonin was  found  to  be  a  sensitive  tool  for    early  diagnosis  
and    predicting  the  outcome    of  sepsis  when  compared  to    CRP.  But  it  
is  neither  100%  sensitive  nor  100%    specific  to  be  relied  as  a  sole  
marker.  The  greatest  predictability  can  be  achieved  by    the  combination  
of   assays  rather  than  a  single  biomarker  and  as  of  now  culture  remains  
the  gold  standard  in  diagnosing  sepsis.    So  it  is  high  time  to  initiate    
rigorous steps to expand the continuing   search  for  a  definitive  diagnostic  
biomarker  using    multi-centric  studies     based  on  a  harmonized  protocol. 
The  uncertainity  regarding  the  approach  to    empirical    therapy  in  
neonatal sepsis can be  minimised  by  periodic  surveillance  of  the  changing  
susceptibility  trend. Strict antibiotic policy to address the issue of  
antimicrobial resistance   in addition to  good  infection  control  and  earnest  
search for  an  early  diagnostic  marker    widen    the  horizon  of    successful    
encounter  with    sepsis    and    lead  the  neonates    to  the  road  of  health. 
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ANNEXURES 
CONSENT FORM 
 
You, Shri./ Smt./ Kum. _________________________, aged ____ years, S/o / 
D/o / W/o ___________________________, residing at ________________ 
_______________________________________ are request to permit your child to 
be a participant in the research study titled “Correlation between CRP, Procalcitonin 
& blood culture in diagnosis of neonatal sepsis with special reference to the bacteriological 
profile and antibiotic susceptibility pattern of the isolates in CMCH” conducted by        
Dr. Arundadhi M., one of the post graduate trainees in the Dept. of 
Microbiology, Govt. Coimbatore Medical College and Hospital, Coimbatore. 
You are eligible for the study as per the inclusion criteria. You can ask him any 
question or seek from him any clarifications about the study which you may have 
before agreeing to participate in the study. 
Name  : 
Place  : 
Date  : 
Signature : 
 
 
 
                                                           PROFORMA: 
Name:                                                                   Father´s  name: 
Age/Sex:         /365,   ch                                           Address: 
IP No:                                                                      
D.O.B: 
D.O.A: 
Birth weight:              kg                                    Maternal H/O: 
Complaints : 
 
                                                                              Nature of delivery: 
                                                                              Place: 
Examination: 
Cry:                                                                                                                       Temp:           F 
 Activity:                                                                                                                HR:             /min 
Colour:                                                                                                                  RR:              /min 
Tone:                                                                                                                     SpO2:          %                                          
Jaundice:   Y  / N                                                                                                CRT:              sec 
Sucking:    Y/ N 
INVESTIGATIONS:                                       CBC: 
  WBC -              X10³ /µL                    MCH -              pg                                    NEUT%-            % 
   RBC-               X10⁶ /µL                     MCHC-             gm/dl                            LYM-            x10 ³ /µL 
  HGB-                gm/dl                         PLT-                 x 10³   /µL                      MXD-          x10³   /µL 
   HCT-                %                                LYM%-             %                                    NEUT           x10³  /µL 
   MCV-                fl                               MXD%-             %                                    RDW-                fl 
RBS:                                                        CRP:                                          Sr. Procalcitonin: 
Blood Culture:                                                   Others: 
Methodology 
                      Collection of blood sample under strict aseptic precautions. 
               Blood                                                                                  Serum 
Inoculated in BHI broth ( 1 : 10 dilution)                           CRP                              PROCALCITONIN 
Incubated at 37° C                                                                            positive                        >0.5ng/ml 
                                                                                                            negative                        <0.5ng/ml               
Subculture done on 2nd, 5th, 7th day.                                                                                            
                                  BAP                                                         MAC 
                                                                                                                                                                                        
WOC, MINUTE  COLONY                               GC                         LF                            NLF 
                
                                       
             Gram Staining                                             Gram  Staining 
             Catalase                Catalase, Oxidase 
             Coagulase                                                    Motility 
             Biochemical reactions                                Biochemical reactions 
                                                                                
                                                      
 
Antibiotic susceptibility pattern            Antibiotic susceptibility pattern 
 
  
 
 
  
 
 
 
 
 
 
 
 
 
 
MASTER CHART 
CRP PCT WBC
Platelet x 
105
(mg per 
L)
(ng/ ml) X 10
3 (Per 
cu.mm)
(per cu 
mm)
1 B/o Maheshwari 3 Fch Primi CMCH TERM NVD 2.8 CONS Pos 0.78 13.6 2.3 AK,G,AMC,C
TX, CPM, 
VAN,LZ,TP
AMP -
2 B/o  Geetha 17 Mch Multi CMCH PRETERM AVD 2.05 Enterococcus 
faecalis
Neg <0.05 14.1 1.1 LZ,VAN,TP AMP, AMC, 
HLG
-
3 B/o Surya devi 1 Mch Primi Extramural TERM NVD 2.9 NG Neg <0.05 15.8 0.89 - - -
4 B/o Nagalakshmi 2 Mch Primi Extramural TERM NVD 2.1 NG Pos 0.47 3 3.75 - - -
5 B/o Nafeela 1 Mch CMCH PRETERM NVD 2.2 NG Neg <0.05 10.4 4.27 - - -
6 B/o Renuka 2 Fch Primi Extramural TERM AVD 2.5 E.coli Pos 0.82 18.3 1.4 CTX,CTR,CAZ
, CPM, 
CFS,PIT,IPM,
TGL
AK,G -
7 B/o Chandrakala 2 Mch Multi Extramural TERM LSCS 2.9 NG Neg <0.05 12.8 4.62 - - -
8 B/o  Savitha 18 Fch Multi Extramural PRETERM NVD 2.2 NG Pos 0.39 3.7 1.05 - - -
9 B/o Bharathi 12 Mch Primi CMCH PRETERM NVD 2.2 Klebsiella 
pneumoniae
Pos 3.87 2.8 4.32 AK, G, CPM, 
CFS,PIT,IPM,
TGL
CTX, CTR, 
CAZ
POS
10 B/o Chitra 1 Mch Multi Extramural PRETERM AVD 2.1 Staphylococcus 
aureus
Neg 0.92 14.4 2.91 AK,G,AMC,C
TX, CPM, 
VAN,LZ,TP
AMP -
11 B/o maheswari 27 Mch Multi CMCH TERM LSCS 3.2 NG Pos 0.41 11.7 1.12 - - -
12 B/o Sundari 2 Mch Primi CMCH PRETERM LSCS 2.2 NG Neg <0.05 10.3 2.64 - - -
13 B/o Sumathi 2 Fch Primi Extramural TERM NVD 2.7 NG Pos 0.26 4.3 0.9 - - -
14 B/o Sheeba 10 Fch Multi CMCH TERM NVD 2.5 NG Neg <0.05 14.4 3.9 - - -
15 B/o Sindhu 2 Fch Primi Extramural PRETERM LSCS 2.3 NG Pos 0.59 17.7 1.03 - - -
16 B/o Kaleeswari 1 Fch Primi CMCH PRETERM LSCS 2.15 Acinetobacter 
baumannii
Neg 1.26. 9.7 3.5 AK, G, 
CTX,CTR,CAZ
, CPM, 
CFS,PIT,IPM,
TGL
- -
Place     of 
birth
Correlation between  C-reactive protein, Serum pro-calcitonin & blood culture in diagnosis of 
neonatal sepsis with special reference to the anti-biotic susceptibility pattern of the isolates at CMCH.
S.No Name
Age
 (days)
Sex Gravida D.D. TESTMATURITY MOD BW (kg) Blood culture sensitive Resistant
CRP PCT WBC
Platelet x 
105
(mg per 
L)
(ng/ ml) X 10
3 (Per 
cu.mm)
(per cu 
mm)
Place     of 
birth
Correlation between  C-reactive protein, Serum pro-calcitonin & blood culture in diagnosis of 
neonatal sepsis with special reference to the anti-biotic susceptibility pattern of the isolates at CMCH.
S.No Name
Age
 (days)
Sex Gravida D.D. TESTMATURITY MOD BW (kg) Blood culture sensitive Resistant
17 B/O Revathy 2 Mch Primi Extramural TERM LSCS 2.3 NG Pos 0.29 13.2 0.94 - - -
18 B/o Bavani 1 Fch Primi CMCH PRETERM NVD 2 NG Neg <0.05 2.4 0.84 - - -
19 B/o Kalavathy 3 Fch Multi CMCH TERM NVD 2.9 NG Neg 0.4 12.6 1.9 - - -
20 B/o Parvathy 3 Mch Multi Extramural TERM NVD 3 CONS Neg <0.05 10.2 0.72 AMC,CTX, 
CPM, 
VAN,LZ,TP
AK,G, AMP -
21 B/o Amsaveni 2 Fch Primi CMCH PRETERM LSCS 2.25 CONS Pos 0.82 8.4 0.81 AK,G,AMC,C
TX, CPM, 
VAN,LZ,TP
AMP -
22 B/o Sangeetha 1 Multi Extramural TERM LSCS 2.8 NG Neg 0.33 17.4 2.6 - - -
23 B/o Ranganayaki 12 Mch Multi Extramural TERM LSCS 2.6 NG Neg <0.05 3.7 1.12 - - -
24 B/o Muthulakshmi 16 Mch Multi CMCH PRETERM 2.4 NG Pos <0.05 11.6 1.2 - - -
25 B/o Priya 3 Fch Primi Extramural TERM LSCS 2.8 NG Neg 0.2 13.1 3.12 - - -
26 B/o Sulochana 10 Fch Multi CMCH PRETERM NVD 2.1 NG Neg <0.05 16.2 2.63 - - -
27 B/o  Riyana 3 Mch Multi CMCH TERM LSCS 3 NG Pos <0.05 12.3 0.56 - - -
28 B/o  Sathya 3 Fch Primi CMCH PRETERM NVD 2.15 NG Neg 0.72 9.5 2.97 - - -
29 B/o Haripriya 1 Mch Primi Extramural PRETERM NVD 2.2 Acinetobacter 
baumannii
Neg 0.98 10.5 0.85   IPM,TGL AK,G,CTR,CT
X, AK, CFS, 
PIT,CPM
NEG
30 B/o Kalavathy 3 Fch Multi Extramural PRETERM LSCS 2.6 NG Neg 0.32 8.4 2.34 - - -
31 B/o Anitha 18 Mch Primi CMCH TERM LSCS 2.1 NG Pos 0.43 16.3 1.04 - - -
32 B/o Sivagami 2 Fch Multi Extramural PRETERM NVD 2.2 Klebsiella 
pneumoniae
Neg 1.48 11.1 2.12 AK, G, 
CTX,CTR,CAZ
, CPM, 
CFS,PIT,IPM,
TGL
- -
33 B/o Geetha 16 Mch Multi Extramural TERM AVD 2.9 Klebsiella 
pneumoniae
Pos 2.82 3.4 3.83   
IPM,TGL,CFS
AK,G,CTX,CT
R,CAZ, ,PIT, 
CPM
NEG
CRP PCT WBC
Platelet x 
105
(mg per 
L)
(ng/ ml) X 10
3 (Per 
cu.mm)
(per cu 
mm)
Place     of 
birth
Correlation between  C-reactive protein, Serum pro-calcitonin & blood culture in diagnosis of 
neonatal sepsis with special reference to the anti-biotic susceptibility pattern of the isolates at CMCH.
S.No Name
Age
 (days)
Sex Gravida D.D. TESTMATURITY MOD BW (kg) Blood culture sensitive Resistant
34 B/o Uma 1 Mch Multi Extramural TERM LSCS 2.6 NG Neg <0.05 14.2 3.41 - - -
35 B/o Roukiya 1 Fch Primi Extramural TERM NVD 2.4 NG Pos <0.05 9.6 0.98 - - -
36 B/o Kareena 1 Fch Primi CMCH TERM LSCS 2.7 NG Neg 0.21 3.1 2.37 - - -
37 B/o Jayanthi 2 Fch Primi Extramural TERM LSCS 2.25 NG Neg 0.36 12.8 2.18 - - -
38 B/o Reeta devi 2 Fch Multi Extramural TERM AVD 2.6 Staphylococcus  
aureus
Pos 3.01 11.2 0.93 AMC, G, 
VAN,LZ,TP
AMP,AK, 
CTX,CPM
-
39 B/o Santhamani 2 Fch Primi CMCH TERM NVD 2.4 NG Neg <0.05 9.3 2.67 - - -
40 B/o  Jothimani 7 Mch Multi Extramural TERM AVD 2.3 NG Pos <0.05 8.6 2.78 - - -
41 B/o Raji 2 Mch Primi CMCH TERM NVD 2.9 NG Neg <0.05 21.3 2.91 - - -
42 B/o Sudha 1 Fch Primi Extramural PRETERM NVD 2.1 Klebsiella 
pneumoniae
Neg 2.03 13.1 3.72  CPM, 
CFS,PIT, 
IPM,TGL
AK,G,CTX,CT
R,CAZ
POS
43 B/o Jayanthi 7 Fch Multi Extramural TERM LCSC 3 NG Pos 0.12 14.2 1.93 - - -
44 B/o Sujitha 1 Mch Primi CMCH TERM NVD 2.75 NG Neg <0.05 12.7 1.21 - - -
45 B/o Sivagami 1 Mch Multi Extramural TERM AVD 2.8 NG Pos <0.05 10.6 3.32 - - -
46 B/o Chitra devi 1 Fch Multi CMCH TERM NVD 2.5 NG Neg <0.05 15.1 2.56 - - -
47 B/o Ramya malar 28 Mch Multi Extramural TERM LSCS 2.3 NG Neg 0.21 3.7 2.93 - - -
48 B/o Kavya 2 Mch Primi Extramural TERM AVD 2.9 Acinetobacter 
baumannii
Pos 0.88 11.6 3.12 AK, G, CTX, 
CTR,CAZ, 
CPM, 
CFS,PIT,IPM,
TGL
- -
49 B/o Soniya 1 Mch Multi Extramural PRETERM NVD 2.1 NG Neg <0.05 1.7 0.86 - - -
50 B/o Subba kumari 7 Fch Multi CMCH TERM AVD 2.9 NG Pos 0.31 9.4 2.45 - - -
51 B/o Arthiammal 1 Mch Primi Extramural PRETERM NVD 2.4 Enterococcus 
faecalis
Neg 0.56 13.8 1.15 HLG,AMP,A
MC,LZ,VAN,T
P
- -
52 B/o Jayalakshmi 1 Fch Multi CMCH TERM LSCS 3.1 NG Neg <0.05 7.3 0.94 - - -
CRP PCT WBC
Platelet x 
105
(mg per 
L)
(ng/ ml) X 10
3 (Per 
cu.mm)
(per cu 
mm)
Place     of 
birth
Correlation between  C-reactive protein, Serum pro-calcitonin & blood culture in diagnosis of 
neonatal sepsis with special reference to the anti-biotic susceptibility pattern of the isolates at CMCH.
S.No Name
Age
 (days)
Sex Gravida D.D. TESTMATURITY MOD BW (kg) Blood culture sensitive Resistant
53 B/o Vanitha 1 Mch Primi Extramural TERM NVD 2.8 NG Pos 0.12 9.2 1.74 - - -
54 B/o Shobana 8 Mch Multi CMCH TERM NVD 2.9 NG Neg <0.05 11.9 1.07 - - -
55 B/o Ranjitha 1 Mch Multi Extramural NVD 2.2 NG Neg 0.37 12.4 3.23 - - -
56 B/o Saranya 3 Mch Multi Extramural PRETERM NVD 2.4 NG Neg <0.05 12.3 3.2 - - -
57 B/o Shoba 2 Fch Primi Extramural TERM LSCS 2.6 NG Neg <0.05 7.4 1.18 - - -
58 B/o Sindhu 3 Fch Multi CMCH TERM AVD 2.9 Klebsiella 
pneumoniae
Neg 0.97 9.5 2.82 AK, G, 
CTX,CTR,CAZ
, CPM, 
CFS,PIT,IPM,
TGL
- -
59 B/o Valarmathi 1 Fch Multi Extramural PRETERM LSCS 2.1 Klebsiella 
pneumoniae
Neg 2.94 8.3 1.25 AK, G, CTR, 
CFS,PIT,IPM,
TGL
CTX,  CAZ, 
CPM
-
60 B/o Muthumeena 3 Fch Multi Extramural TERM NVD 3.1 NG POS 0.25 3.6 2.23 - - -
61 B/o Jeeva 1 Mch Primi CMCH PRETERM NVD 2.3 NG Neg <0.05 8.4 2.8 - - -
62 B/o Rabitha 3 Mch Primi Extramural PRETERM NVD 2.4 CONS NEG 0.98 12.3 3.34 AMC,CTX, 
CPM, 
VAN,LZ,TP
AK,G -
63 B/o Saranya 1 Mch Primi Extramural TERM LSCS 2.9 NG Neg 0.41 11.3 0.92 - - -
64 B/o Jeeva 2 Fch CMCH TERM LSCS 2.4 NG Neg <0.05 16.4 0.84 - - -
65 B/o Fathima 3 Fch Extramural PRETERM NVD 2.25 NG Pos 0.38 13.2 2.74 - - -
66 B/o Sujatha 1 Mch Primi Extramural TERM AVD 2.5 Klebsiella 
pneumoniae
POS 0.91 3.1 2.43   
CTX,CTR,CAZ
, CPM, 
CFS,PIT,IPM,
TGL
AK,G -
67 B/o Ramya 1 Fch Primi CMCH TERM NVD 2.75 NG Neg <0.05 8.4 0.97 - - -
68 B/o Sudha 7 Mch Multi CMCH TERM AVD 3 NG Neg 0.15 6.8 2.21 - - -
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69 B/o Muthulakshmi 2 Mch Multi Extramural PRETERM NVD 2.1 Klebsiella 
pneumoniae
Pos 1.26 12.5 3.21 AK, G, CPM, 
CFS,PIT,IPM,
TGL
CTX, CTR, 
CAZ
POS
70 B/o Indumathi 16 Mch Multi Extramural TERM LSCS 2.6 NG Pos 0.71 3.6 0.87 - - -
71 B/o Saranya 1 Fch Primi CMCH TERM NVD 2.8 NG Neg <0.05 13.4 3.21 - - -
72 B/o Poongodi 8 Mch Multi CMCH TERM LSCS 2.6 NG Neg 0.41 11.3 1.23 - - -
73 B/o Gunasundari 3 FCH Multi CMCH TERM LSCS 2.6 CONS Neg <0.05 2.8 2.69 AMC,CTX, 
CPM, VAN, 
AK,G, LZ,TP
AMP -
74 B/o Nandhini 1 Mch Multi Extramural PRETERM NVD 2.3 Klebsiella 
pneumoniae
Pos 0.78 14.5 2.45 AK, G, CTX, 
CTR,CAZ, 
CPM, 
CFS,PIT,IPM,
TGL
- -
75 B/o Uma 1 Fch Primi CMCH PRETERM NVD 2.1 NG Neg <0.05 12.8 0.95 - - -
76 B/o Aysammal 15 Mch Multi Extramural TERM AVD 2.5 Klebsiella 
pnumoniae
Neg 2.1 13.6 1.12 AK, G, 
CTX,CTR,CAZ
, CPM, 
CFS,PIT,IPM,
TGL
- -
77 B/o Anjali 1 Fch Primi CMCH PRETERM NVD 2.25 Klebsiella 
pneumoniae
Neg 1.04 12.7 3.56    CFS,PIT, 
IPM,TGL
AK,G,CTX,CT
R,CAZ,CPM
POS
78 B/o Manimekalai 2 Mch Primi CMCH TERM LSCS 2.6 NG Pos 0.33 11.7 0.85 - - -
79 B/o Chitra 3 Mch Multi Extramural PRETERM NVD 2.9 Staphylococcus 
aureus
Pos 2.96 9.2 2.45 AK,AMC,CTX, 
CPM, 
VAN,LZ,TP
AMP,G -
80 B/o Rasathi 2 Fch Multi CMCH TERM NVD 3.1 Klebsiella 
pneumoniae
Pos 0.99 7.45 1.21 AK, G, 
CTX,CTR,CAZ
, CPM, 
CFS,PIT,IPM,
TGL
- -
81 B/o Revathi 2 Mch Primi CMCH PRETERM LSCS 2.1 NG Neg 0.16 2.6 2.17 - - -
82 B/o Pavithra devi 3 Fch Multi Extramural TERM LSCS 3 NG Neg <0.05 14.7 1.38 - - -
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83 B/O Sudha 3 Mch Primi Extramural PRETERM NVD 2.2 NG Pos 1.12 12.5 2.54 - - -
84 B/o Palanal 2 Mch Multi Extramural TERM AVD 2.6 Klebsiella 
pneumoniae
Pos 1.27 10.7 1.74 AK, G,  CPM, 
CFS,PIT, 
IPM,TGL
CTX, CTR, 
CAZ
POS
85 B/o uma 1 Mch Multi Extramural TERM LSCS 2.4 NG Neg <0.05 9.2 1.24 - - -
86 B/o Sudha Ramesh 7 Mch Primi CMCH TERM NVD 2.9 NG Neg <0.05 8.4 2.59 - - -
87 B/o Usha 1 Mch Primi Extramural PRETERM LSCS 2.2 Klebsiella 
pneumoniae
Pos 0.78 3.23 1.17 AK, G, 
CTX,CTR,CAZ
, CPM, 
CFS,PIT,IPM,
TGL
- -
88 B/o Vijayalakshmi 27 Mch Multi Extramural PRETERM LSCS 2.3 NG Neg 0.64 7.6 2.84 - - -
89 B/o Mariammal 1 Mch Multi CMCH TERM NVD 2.4 NG Pos 0.11 11.4 0.87 - - -
90 B/o Parimala 2 Fch Primi Extramural PRETERM LSCS 2.3 NG Neg <0.05 12.5 1.41 - - -
91 B/o Maheshwari 1 Mch Primi CMCH PRETERM NVD 2.2 CONS Pos 1.42 4.3 3.17 AK,G, CPM, 
VAN,LZ,TP
AMC, 
AMP,CTX
-
92 B/o Bagavathy 3 Fch Primi Extramural PRETERM NVD 2.1 NG Neg <0.05 11.5 2.67 - - -
93 B/o Shanthi 1 Fch Primi CMCH TERM NVD 2.5 Klebsiella 
pneumoniae
Pos 0.94 7.8 1.3 AK, G,  CPM, 
,IPM,TGL
CTX, CTR, 
CAZ,CFS,PIT,
CPM
NEG
94 B/o Ramya 1 Mch Multi CMCH PRETERM LCSC 2.2 Klebsiella 
pneumoniae
Neg <0.05 15.3 3.21 AK, CPM, 
CFS,PIT,IPM,
TGL
CTX, CTR, 
CAZ,G
POS
95 B/o Kunjal 1 Mch Multi Extramural TERM NVD 2.8 NG Pos 0.81 12.8 1.4 - - -
96 B/o Manju 3 Mch Multi Extramural PRETERM AVD 2.1 Klebsiella 
pneumoniae
Pos 0.26 3.8 2.56  
CTX,CTR,CAZ
, CPM, 
CFS,PIT,IPM,
TGL
AK,G -
97 B/o Kowsalya Mary 1 Mch Primi CMCH TERM NVD 2.9 NG Pos 0.12 13.6 1.17 - - -
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98 B/o Kasthuri 1 Mch Multi Extramural TERM AVD 2.25 NG Neg <0.05 2.3 2,72 - - -
99 B/o Rathnavel 1 Fch Multi CMCH PRETERM NVD 2.1 NG Neg <0.05 9.5 0.98 - - -
100 B/o Shenbaga priya 2 Fch Primi Extramural TERM LSCS 3.1 Klebsiella 
pneumoniae
Pos 0.84 8.6 0.94 AK, G, 
CTX,CTR,CAZ
, CPM, 
CFS,PIT,IPM,
TGL
- -
101 B/o Panjali 1 Mch Multi Extramural TERM NVD 2.45 NG Pos 0.27 12.7 2.37 - - -
102 B/o Vishnu priya 1 Mch Primi Extramural TERM NVD 2.6 NG Neg 0.16 16.3 3.63 - - -
103 B/o Gayathri 1 Mch Multi CMCH TERM NVD 2.8 E.coli Pos 0.95 9.4 1.3 CFS,PIT,IPM,
TGL
AK, G, 
CTX,CTR,CAZ
, CPM,
POS
104 B/o Punitha 2 Fch Primi Extramural PRETERM LSCS 2.2 NG Pos 0.25 6.8 1.13 - - -
105 B/o Lakshmi 1 Fch Primi Extramural TERM NVD 2.4 NG Neg <0.05 2.6 2.18 - - -
106 B/o Esther 1 Fch Primi Extramural PRETERM AVD 2.3 Klebsiella 
pneumoniae
Neg 1.96 11.7 3.72 AK, G, CPM, 
CFS,PIT, 
IPM,TGL
CTX, CTR, 
CAZ
POS
107 B/o Vanitha 8 Mch Multi Extramural TERM LSCS 3 NG Neg <0.05 13.7 3.47 - - -
108 B/o Selvi 2 Mch Primi CMCH PRETERM NVD 2.3 NG Pos 2.26 10.4 1.07 - - -
109 B/o Gayathri 2 Mch Multi Extramural TERM NVD 2.7 Staphylococcus 
aureus
Neg 1.52 12.9 1.23 AMC,CTX, 
CPM, 
VAN,LZ,TP
AMP,AK,G
110 B/o Sagitha banu 3 Fch Multi Extramural TERM NVD 2.3 Klebsiella 
pneumoniae
Pos 1.82 11.6 3.41  
CTX,CTR,CAZ
, CPM, 
CFS,PIT,IPM,
TGL
AK,G -
111 B/o Kowsalya 23 Fch Multi Extramural TERM LSCS 2.7 NG Neg 0.41 13.7 1.05 - - -
112 B/o Banupriya 22 Mch Primi CMCH PRETERM NVD 2.2 NG Neg 0.51 11.3 1.35 - - -
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113 B/o Kogila 3 Fch Primi Extramural TERM AVD 3 NG Pos 0.32 8.5 1.4 - - -
114 B/o Reenadevi 2 Fch Multi Extramural TERM AVD 2.7 Klebsiella 
pneumoniae
Neg 1.22 11.8 2.72 AK, G, 
CTX,CTR,CAZ
, CPM, 
CFS,PIT,IPM,
TGL
- -
115 B/o Soundarya 1 Mch Multi CMCH TERM NVD 2.5 NG Neg <0.05 10.3 1.01 - - -
116 B/o Veeralakshmi 1 Fch Multi CMCH PRETERM NVD 2.25 Klebsiella 
pneumoniae
Pos 1.02 3.1 2.83 AK, CPM, 
CFS,PIT,IPM,
TGL
CTX, CTR, 
CAZ,G, CPM
POS
117 B/o Rukmani 3 Mch Multi Extramural TERM NVD 2.3 NG Pos 1.24 7.5 1.05 - - -
118 B/o Premavani 2 Fch Multi Extramural TERM AVD 2.5 NG Neg <0.05 8.9 2.62 - - -
119 B/o Ponnamal 3 Mch Primi Extramural PRETERM NVD 2.1 NG Neg <0.05 14.8 1.38 - - -
120 B/o Latha 2 Mch Multi CMCH TERM AVD 2.7 E.coli Pos 1.72 18.3 3.61 AK, G, 
CTX,CTR,CAZ
, CPM, 
CFS,PIT,IPM,
TGL
- -
121 B/o Indumathy 3 Fch Multi CMCH PRETERM NVD 2.2 NG Neg 0.11 7.2 1.45 - - -
122 B/o Valarmathy 1 Mch Multi Extramural TERM AVD 2.8 NG Neg <0.05 10.8 2.28 - - -
123 B/o Nithya 1 Mch Primi CMCH PRETERM NVD 2.15 NG Pos 0.27 8.7 1.17 - - -
124 B/o Radha 2 Fch Multi Extramural TERM LSCS 3.1 NG Neg <0.05 12.5 1.36 - - -
125 B/o Manidevi 3 Mch Multi CMCH TERM NVD 2.3 NG Pos 0.56 3.7 2.72 - - -
126 B/o Prabavathy 8 Fch Primi Extramural TERM NVD 2.5 Klebsiella 
pneumoniae
Pos 3.11 15.3 1.4 AK, G,   CPM, 
, 
PIT,IPM,TGL
  CTX,CTR, 
CAZ,CFS
NEG
127 B/o Viji 1 Mch Multi Extramural PRETERM LSCS 2.05 Klebsiella 
pneumoniae
Neg 1.92 11.6 3.73 CTX,CTR,CAZ
, CPM, 
CFS,PIT,IPM,
TGL
AK,G -
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128 B/o Sudha 2 Mch Multi CMCH TERM LSCS 2.5 NG Pos 0.75 7.9 0.98 - - -
129 B/o Rajeshwari 1 Fch PRIMI CMCH PRETERM NVD 2.25 Klebsiella 
pneumoniae
Pos 0.65 12.2 2.88 AK, G,  CPM, 
CFS,PIT, 
IPM,TGL
CTX, CTR, 
CAZ
POS
130 B/o Banu 1 Mch PRIMI Extramural TERM LSCS 2.3 NG Neg <0.05 7.3 1.9  - -
131 B/oSelvambigai 1 Fch Multi CMCH TERM LSCS 2.5 NG Pos 0.31 20.6 1.31 - - -
132 B/o Rasathi 8 Mch Multi Extramural PRETERM NVD 2.1 NG Neg 0.27 14.1 3.42 - - -
133 B/o Fathima 9 Fch Primi CMCH TERM LSCS 3.1 NG Neg <0.05 13.2 2.46 - - -
134 B/o Sunaina 3 Fch Multi Extramural PRETERM NVD 2.2 NG Pos 0.56 14.1 1.16 - - -
135 B/o Lakshmi 7 Mch Multi Extramural TERM LSCS 2.75 NG Pos 0.2 8.8 1.73 - - -
136 B/o Divya Bharathi 12 Mch Primi CMCH TERM NVD 2.3 NG Neg <0.05 15 1.18 - - -
137 B/O Latha 2 Fch Primi Extramural TERM AVD 2.5 NG Neg <0.05 11.4 1.45 - - -
138 B/o Anandha lakshmi 1 Mch PRIMI Extramural TERM NVD 2.6 Group B 
streptococci
Pos <0.05 15.3 0.98 AMP,AMC,C
TX,CTR,G,LZ,
VAN,TP
- -
139 B/o Kokila 1 Mch Multi CMCH TERM NVD 2.8 NG Neg <0.05 11.8 1.95 - - -
140 B/o Laxmi 8 Fch Multi Extramural TERM LCSC 2.4 NG Neg <0.05 13.7 1.38 - - -
141 B/o Sunitha 2 Mch Primi Extramural TERM NVD 2.6 NG Neg 0.33 12.8 3.56 - - -
142 B/o  Ramzan Banu 1 Fch Multi CMCH PRETERM AVD 2.1 NG Neg <0.05 10.4 1.24 - - -
143 B/o Nagarathinam 10 Mch Multi Extramural TERM NVD 2.6 NG Pos 0.93 11.7 2.45 - - -
144 B/o Palaniammal 3 Mch Primi Extramural TERM AVD 2.8 NG Pos 0.49 12.3 1.32 - - -
145 B/o Mariammal 8 Fch Multi CMCH TERM NVD 3 NG Neg 0.26 8.3 2.17 - - -
146 B/o Gowthami 2 Fch Primi CMCH PRETERM LSCS 2.1 NG Neg <0.05 14.5 1.1 - - -
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147 B/o Maragatham 2 Mch Multi Extramural PRETERM NVD 2.4 Klebsiella 
pneumoniae
Pos 0.79 4.7 2.39 AK, G, 
CTX,CTR,CAZ
, CPM, 
CFS,PIT,IPM,
TGL
- -
148 B/o Meena 1 Fch Primi Extramural TERM NVD 2.6 NG Neg <0.05 7.2 1.47 - - -
149 B/o Mani 1 Fch Primi CMCH PRETERM LSCS 2.3 Klebsiella 
pneumoniae
Pos 1.02 23.6 3.72 CTR, 
CTX,CPM, 
PIT,IPM,TGL
AK,G, 
CAZ,CFS
NEG
150 B/o Chitra 13 Mch Multi CMCH PRETERM NVD 2.1 NG Pos <0.05 13.6 2.41 - - -
151 B/o Vidya 5 Fch Primi Extramural PRETERM AVD 2.2 Klebsiella 
pneumoniae
Pos 0.96 9.5 1.23 AK, G, 
CTX,CTR,CAZ
, CPM, 
CFS,PIT,IPM,
TGL
- -
152 B/o Sakunthala 2 Mch Multi Extramural TERM LSCS 2.5 NG Neg <0.05 10.5 1.73 - - -
153 B/o Sumaiya Begum 11 Fch Primi CMCH TERM NVD 3.2 NG Pos 0.81 23.2 1.19 - - -
154 B/o Valli nayaki 3 Mch Primi Extramural TERM AVD 2.75 Klebsiella 
pneumoniae
Neg 0.85 13.3 2.47 AK, G,  CPM, 
CFS,PIT, 
IPM,TGL
CTX, CTR, 
CAZ
POS
155 B/o Parvathy 7 Fch Multi CMCH TERM LSCS 2.9 NG Neg <0.05 12.1 1.03 - - -
156 B/o Sumathi Vasan 9 Fch Multi Extramural PRETERM NVD 2.3 NG Pos 0.37 3.4 1.19 - - -
157 B/o Ajantha Kumari 2 Mch Primi Extramural PRETERM LSCS 2.2 Staphlococcus 
aureus
Pos 1.44 4.2 1.38 AK,,AMC, 
CPM, 
VAN,LZ,TP
AMP,G,CTX -
158 B/o Vijaya lakshmi 2 Fch Multi CMCH TERM NVD 2.4 NG Neg <0.05 10.6 1.12 - - -
159 B/o Vanmathi 2 Mch Multi CMCH TERM AVD 3.1 NG Neg 0.33 13.7 1.13 - - -
160 B/o Anna poorani 27 Mch Multi Extramural PRETERM NVD 2.25 Klebsiella 
pneumoniae
Pos 0.87 11.8 2.46 AK, G, CPM, 
CFS,PIT, 
IPM,TGL
CTX, CTR, 
CAZ
POS
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161 B/O Vasanthi 3 Fch Primi Extramural TERM NVD 2.3 NG Neg <0.05 13.7 2.26 - - -
162 B/o Banu 2 Mch Multi Extramural PRETERM LCSC 2.25 NG Neg <0.05 16.2 1.14 - - -
163 B/o Renuka 3 Mch Primi Extramural TERM NVD 3.1 NG Pos 0.18 11.3 2.72 - - -
164 B/oAlagumani 3 Fch Multi CMCH TERM AVD 2.6 NG Neg <0.05 9.6 2.48 - - -
165 B/o Kasthuri 2 Fch Primi Extramural TERM NVD 2.8 Acinetobacter 
baumannii
Pos 0.7 2.3 1.26 CTX,CTR,CAZ
, CPM, 
CFS,PIT,IPM,
TGL
AK, G -
166 B/o Sheela 8 Mch Primi Extramural PRETERM AVD 2.15 Group B 
StreptococcI
Pos 0.62 13.1 3.46 LZ,VAN,TP,A
MP, AMC, 
CTX,CTR
G -
167 B/o Baby 1 Fch Multi CMCH TERM LSCS 3 E.coli Pos 1.96 15.3 2.41 AK, G, , CPM, 
CFS,PIT,IPM,
TGL
CTX, 
CTR,CAZ
POS
168 B/o Sumathi 9 Mch Primi CMCH PRETERM NVD 2.3 NG Neg <0.05 15.6 1.27 - - -
169 B/o Shanthi 2 Fch Primi Extramural TERM NVD 2.75 NG Pos 0.11 17.1 1.73 - - -
170 b/o Uma 3 Fch Primi CMCH PRETERM LSCS 2.1 NG Neg <0.05 5.8 0.94 - - -
171 B/o Deepa 1 Mch Multi CMCH TERM LSCS 2.5 NG Pos 0.36 24.3 2.36 - - -
172 B/o Jayalakshmi 1 Mch Multi Extramural TERM NVD 2.8 NG Pos 0.71 3.2 1.33 - - -
173 B/o Parimala 1 Fch Multi Extramural PRETERM AVD 2.1 NG Neg <0.05 12.5 1.82 - - -
174 B/o Soundarya 8 Fch Primi Extramural TERM LSCS 2.9 NG Neg 0.72 10.1 0.73 - - -
175 B/o Mythili 2 Fch Multi CMCH TERM AVD 2.25 Acinetobacter 
baumannii
Neg 0.65 8.2 3.37 AK,  
CTX,CTR,CAZ
, CPM, 
CFS,PIT,IPM,
TGL
G -
176 B/o  Latha 26 Mch Multi Extramural TERM LSCS 2.45 NG Pos 0.12 2.9 1.18 - - -
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177 B/o eswari 3 Fch Primi Extramural PRETERM LSCS 2.25 NG Neg <0.05 17.3 2.03 - - -
178 B/o Chitra 1 Fch Multi CMCH PRETERM NVD 2.2 Klebsiella 
pnuemoniae
Pos 0.79 6.8 1.36 CTX,CTR,CAZ
, CPM, 
CFS,PIT,IPM,
TGL
AK,G -
179 B/o Sudha 7 Mch Primi Extramural PRETERM LSCS 2.3 NG Pos 0.11 18.9 2.77 - - -
180 B/o Annapoorani 28 Mch Multi CMCH TERM NVD 2.4 NG Neg <0.05 11.4 0.99 - - -
181 B/o Esther 3 Fch Primi Extramural PRETERM AVD 2.2 NG Pos 0.56 10.7 1.47 - - -
182 B/o  Jayanthi 2 Fch Primi CMCH TERM NVD 2.5 NG Neg 0.38 8.9 1.71 - - -
183 B/o Nisha 1 Fch Primi CMCH TERM NVD 2.8 Staphylococcus  
aureus
Neg <0.05 12.6 1.23 AK,G,AMC,C
TX, CPM, 
VAN,LZ,TP
AMP -
184 B/o Nandhini 1 Mch Multi Extramural PRETERM LCSC 2.2 NG Neg <0.05 18.5 2.26 - - -
185 B/o  Santha 3 Mch Primi Extramural TERM NVD 2.7 NG Neg <0.05 7.1 1.27 - - -
186 B/O Vanitha 2 Fch Primi CMCH TERM AVD 2.5 NG Pos 0.17 13.3 1.3 - - -
187 B/o Priya 12 Fch Multi Extramural PRETERM AVD 2.2 Acinetobacter 
baumannii
Pos 0.81 13.7 2.72 AK, G, 
,IPM,TGL, 
PIT
CTX,CTX 
CAZ, CPM,  
CFS
NEG
188 B/o Jothiswari 1 Mch Multi Extramural TERM NVD 2.3 NG Neg <0.05 9.4 1.19 - - -
189 B/o Manjula devi 2 Mch Multi Extramural TERM LSCS 2.9 NG Pos <0.05 13.8 1.82 - - -
190 B/o Sulthana 2 Fch Primi CMCH PRETERM NVD 2.1 NG Neg 0.76 16.7 1.41 - - -
191 B/o Anitha 8 Fch Multi Extramural TERM LSCS 2.9 NG Neg <0.05 10.3 3.38 - - -
192 B/o geetha 3 Mch Multi CMCH TERM NVD 2.5 Staphylococcus 
aureus
Pos 0.94 6.8 1.03 AK,AMP,G,A
MC,CTX, 
CPM, 
VAN,LZ,TP
- -
193 B/o Sudha 1 Fch Primi CMCH TERM LSCS 3.1 NG Neg <0.05 18.4 1.39 - - -
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194 B/o Sayeed 1 Mch Multi Extramural PRETERM NVD 2.1 Klebsiella 
pneumoniae
neg 1.04 13.7 2.47 AK, G,  CPM, 
CFS,PIT, 
IPM,TGL
CTX, CTR, 
CAZ
POS
195 B/o Nandhini 1 Fch Primi CMCH TERM AVD 2.5 NG Neg <0.05 21.8 1.1 - - -
196 B/o Sparnisha 9 Mch Multi Extramural PRETERM LSCS 2.4 NG Neg <0.05 9.7 2.72 - - -
197 B/o Rathinam 3 Fch Primi CMCH TERM NVD 2.8 NG Pos 0.71 15.6 1.17 - - -
198 B/o Sakteeshwari 2 Mch Primi CMCH PRETERM NVS 2.1 Klebsiella 
pneumoniae
Pos 0.97 8.3 1.83 AK,  
CTX,CTR,CAZ
, CPM, 
CFS,PIT,IPM,
TGL
G -
199 B/o Maragatham 12 Fch Primi Extramural TERM LSCS 2.9 Staphylococcus 
aureus
Pos 1.41 24.6 3.83 AK,G, CTX, 
CPM, 
VAN,LZ,TP
AMC, AMP -
200 B/o Sangeetha 2 Mch Multi CMCH TERM NVD 2.25 NG Pos 0.81 12.3 1.22 - - -
KEY TO MASTER CHART 
Fch  - Female child 
Mch  - Male child 
Primi  - Primigravida 
Multi  - Multigravida 
CMCH - Coimbatore Medical College Hospital 
Neg  - Negative 
Pos  - Positive  
D.D test - Double disc potentiation test 
AMP   - Ampicillin 
AK  - Amikacin 
G  - Gentamicin 
AMC  - Amoxy clavulanic acid 
CTX  - Cefotaxime 
CTR  - Ceftriaxone 
CAZ  - Ceftazidime 
CPM  - Cefepime 
CFS  - Cefoperazone sulbactum 
PIT  - Piperacillin-tazobactam 
VAN  - Vancomycin 
LZ  - Linezolid 
IPM  - Imepenem 
TGL  -Tigecycline 
TP  - Teicoplanin 
NG   - No growth 
MOD  - Mode of delivery 
BW  - Birth Weight 
HLG  - High level gentamicin 
